<Publications>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30080852</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>01</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1935-2735</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2018</Year>
                        <Month>08</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PLoS neglected tropical diseases</Title>
                <ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0006629</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0006629</ELocationID>
            <Abstract>
                <AbstractText>International sustainable development goals for the elimination of viral hepatitis as a public health problem by 2030 highlight the pressing need to optimize strategies for prevention, diagnosis and treatment. Selected or transmitted resistance associated mutations (RAMs) and vaccine escape mutations (VEMs) in hepatitis B virus (HBV) may reduce the success of existing treatment and prevention strategies. These issues are particularly pertinent for many settings in Africa where there is high HBV prevalence and co-endemic HIV infection, but lack of robust epidemiological data and limited education, diagnostics and clinical care. The prevalence, distribution and impact of RAMs and VEMs in these populations are neglected in the current literature. We therefore set out to assimilate data for sub-Saharan Africa through a systematic literature review and analysis of published sequence data, and present these in an on-line database (https://livedataoxford.shinyapps.io/1510659619-3Xkoe2NKkKJ7Drg/). The majority of the data were from HIV/HBV coinfected cohorts. The commonest RAM was rtM204I/V, either alone or in combination with associated mutations, and identified in both reportedly treatment-na√Øve and treatment-experienced adults. We also identified the suite of mutations rtM204V/I + rtL180M + rtV173L, that has been associated with vaccine escape, in over 1/3 of cohorts. Although tenofovir has a high genetic barrier to resistance, it is of concern that emerging data suggest polymorphisms that may be associated with resistance, although the precise clinical impact of these is unknown. Overall, there is an urgent need for improved diagnostic screening, enhanced laboratory assessment of HBV before and during therapy, and sustained roll out of tenofovir in preference to lamivudine alone. Further data are needed in order to inform population and individual approaches to HBV diagnosis, monitoring and therapy in these highly vulnerable settings.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mokaya</LastName>
                    <ForeName>Jolynne</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">0000-0001-8398-0689</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McNaughton</LastName>
                    <ForeName>Anna L</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hadley</LastName>
                    <ForeName>Martin J</ForeName>
                    <Initials>MJ</Initials>
                    <Identifier Source="ORCID">0000-0002-3039-6849</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Oxford University Academic IT Department, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beloukas</LastName>
                    <ForeName>Apostolos</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0001-5639-0528</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Geretti</LastName>
                    <ForeName>Anna-Maria</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goedhals</LastName>
                    <ForeName>Dominique</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, University of the Free State/National Health Laboratory Service, Bloemfontein, Republic of South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matthews</LastName>
                    <ForeName>Philippa C</ForeName>
                    <Initials>PC</Initials>
                    <Identifier Source="ORCID">0000-0002-4036-4269</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID> 110110</GrantID>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D000078182">Systematic Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS Negl Trop Dis</MedlineTA>
            <NlmUniqueID>101291488</NlmUniqueID>
            <ISSNLinking>1935-2727</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017325">Hepatitis B Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017325" MajorTopicYN="N">Hepatitis B Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>02</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>06</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>8</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>8</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30080852</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pntd.0006629</ArticleId>
            <ArticleId IdType="pii">PNTD-D-18-00195</ArticleId>
            <ArticleId IdType="pmc">PMC6095632</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D566-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23125365</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Perspect Med. 2014 Nov 03;4(11):a021550</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25368018</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Feb 18;10(2):e0118062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25693196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2011 Jan;49(1):298-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21048009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Glob Antimicrob Resist. 2017 Mar;8:74-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28017671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2016 Sep;88(9):1560-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26890489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2015;20(6):643-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25852125</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2017 Feb;89(2):257-266</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27458715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Springerplus. 2015 Feb 01;4:43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25674500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2017 Nov 1;17(Suppl 1):693</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29143616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2016 Jan 14;11(1):e0143869</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26764909</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Issues Mol Biol. 2014;16:69-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24014801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Res Ther. 2017 Mar 8;14(1):11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28270215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2014 Dec 1;59(11):1618-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25100867</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Res Notes. 2011 Dec 23;4:561</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22195774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2012 Oct;84(10):1553-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22930502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Glob Health. 2017 Oct;5(10):e992-e1003</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28911765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2014 Feb;52(2):460-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24478474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2011 Dec;49(12):4138-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21956978</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2017 Mar;66(3):645-654</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27771453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2016 Sep;43:232-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27245151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2010;15(3 Pt B):505-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20516572</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2009 Nov;137(5):1593-608.e1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19737565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2010;15(3 Pt B):463-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20516566</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2016 Dec;85:71-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27838494</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2013 Nov 12;31(47):5579-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23973500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Afr Health Sci. 2015 Jun;15(2):328-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26124776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2016 Oct 21;13(1):178</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27769271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Negl Trop Dis. 2017 Oct 5;11(10):e0005842</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28981505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Dec 27;12(12):e0190149</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29281718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2016 Jan 7;22(1):145-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26755866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2017;22(1):13-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27167598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 Jun 10;9(6):e99971</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24915064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2007 Nov;79(11):1650-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17854040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Res Hum Retroviruses. 2017 Sep;33(9):966-969</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28316253</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatric Infect Dis Soc. 2014 Sep;3 Suppl 1:S7-S12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25232477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Res Notes. 2012 Jan 20;5:50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22264264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Resist Updat. 2001 Apr;4(2):118-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11512520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Nephrol. 2012 Sep;8(9):533-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22735764</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2014 Jul;60(3):313-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24836314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Jul 31;12(7):e0181836</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28759595</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2012;17(2):321-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22290198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2010 Sep;48(9):3223-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20631103</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2005;10(6):727-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16218172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2016 Jun;88(6):1035-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26629781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Springerplus. 2016 Oct 28;5(1):1896</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27843753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liver Int. 2011 Jan;31 Suppl 1:111-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21205147</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Jul 28;10(7):e0134037</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26218239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Negl Trop Dis. 2018 Aug 6;12(8):e0006629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30080852</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013;8(3):e59346</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23527168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2013 Apr;57(4):1790-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23380725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2011 Oct;18(10):e447-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21914062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2017 Nov 16;216(suppl_8):S792-S796</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29156043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2014 Dec;29:125-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25449246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2015 Aug 13;15:335</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26268355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2009 Jun;81(6):996-1001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19382250</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2015 Feb;63:12-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25600597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>West Afr J Med. 2011 May-Jun;30(3):164-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22120479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2016 Mar 31;11(3):e0152043</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27032097</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2018 Jan 9;13(1):e0190592</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29315352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Jun 14;12(6):e0179025</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28614401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2017 Aug;67(2):246-254</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28392234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2009 Jul;81(7):1151-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19475624</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2007 Jun 21;356(25):2614-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17582071</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2016 Jan 1;213(1):39-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26136470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2012 Dec;67(12):2939-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22915461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1999 Nov;30(5):1312-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10534356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Res. 2007 Jul;37(s1):S9-S19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17627641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Int AIDS Soc. 2017 Nov;20 Suppl 7:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29171192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2014;57(3-4):218-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25034491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2016 Jul 27;90(16):7171-7183</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27252524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(9):e46345</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23029487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):174-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23892239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2015 Feb;30(2):252-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25318660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomed Sci. 2001 May-Jun;8(3):237-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11385295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2016 Nov;44(10):1005-1017</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27630001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2015 Mar;87(3):388-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25164924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trans R Soc Trop Med Hyg. 2015 Nov;109(11):723-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26386408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2018 Mar 28;217(8):1180-1183</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29351639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2011 Dec;66(12):2715-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21965435</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">29462187</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>05</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>13</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2018</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0193177</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0193177</ELocationID>
            <Abstract>
                <AbstractText>Hepatitis B virus (HBV) prevalence is highest in Sub-Saharan Africa including Ethiopia. HBV genotypes have distinct geographic distributions and play a role in course of infection and treatment management. However, in Ethiopia there is paucity of information about distribution of HBV genotypes. This study was done to determine genotype, mutation and sero-virological profiles of HBV isolates in Southern Ethiopia. Cross-sectional, laboratory based study was conducted on 103HBsAg sero-positive samples from a total of 2,237 screened blood donors. HBV serological markers and biochemical assays were done. Serum viral load was measured using quantitative real-time PCR. Partial HBV S-gene was amplified with nested PCR and sequenced. Bioinformatics tools were utilized to determine genotypes, serotypes and mutations. Of 103 HBsAg reactive serum samples, 14.6% and 70.9% were sero-positive for HBeAg and HBeAb, respectively. Ninety-eight samples gave detectable viral load with a median of 3.46(2.62-4.82) log IU/ml. HBeAg sero-positive donors carried elevated levels of viral load. Eighty five isolates were successfully amplified, sequenced and genotyped into 58 (68.2%) genotype A (HBV/A) and 27 (31.8%) genotype D (HBV/D). HBV serotypes found were adw2 (74.1%), ayw2 (24.7%), and ayw3 (1.2%). In twenty-four (28.2%) samples mutations in the major hydrophilic region (MHR) were observed. Donors infected with HBV/A had higher viral load and more frequent MHR mutation than HBV/D infected donors. This study illustrated distribution of HBV genotype A and D among blood donors in southern Ethiopia. It also demonstrated occurrence HBV variants that may influence clinical aspects of HBV infection. The study contributes in narrowing the existing gap of HBV molecular study in Ethiopia.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ambachew</LastName>
                    <ForeName>Henock</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory, First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory Diagnostics, First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Meijuan</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory, First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory Diagnostics, First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pappoe</LastName>
                    <ForeName>Faustina</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology and Parasitology, Provincial Laboratory of Microbiology and Parasitology and the Key Laboratory of Zoonoses Anhui, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Jilong</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory Diagnostics, First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology and Parasitology, Provincial Laboratory of Microbiology and Parasitology and the Key Laboratory of Zoonoses Anhui, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Yuanhong</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">0000-0002-1637-3800</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory, First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory Diagnostics, First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology and Parasitology, Provincial Laboratory of Microbiology and Parasitology and the Key Laboratory of Zoonoses Anhui, Anhui Medical University, Hefei, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>02</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001782" MajorTopicYN="Y">Blood Donors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005002" MajorTopicYN="N">Ethiopia</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016679" MajorTopicYN="Y">Genome, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>02</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>2</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>2</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">29462187</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0193177</ArticleId>
            <ArticleId IdType="pii">PONE-D-17-37633</ArticleId>
            <ArticleId IdType="pmc">PMC5819820</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(10):e45750</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23049685</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2013;56(5):278-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23887183</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epidemiol Infect. 2003 Aug;131(1):757-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12948377</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Rev. 2007 Jul;20(3):426-39, table of contents</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17630333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2016 Sep 10;388(10049):1081-1088</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27394647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2017 Jun 19;17 (1):438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28629395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2005 Mar 31;23(19):2409-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15752827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2012 Feb;84(2):198-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22170538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2005 Nov 7;11(41):6410-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16425408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2007 Mar;54(3):291-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16911832</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2006 Feb;12(2):198-203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16494742</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ILAR J. 2001;42(2):127-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11406715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Clin Lab Sci. 2004 Autumn;34(4):389-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15648778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Braz J Infect Dis. 2015 Sep-Oct;19(5):525-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25997779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2004;47(6):289-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15564741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Mar 11;350(11):1118-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15014185</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2014;57(3-4):141-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25034481</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2006 Aug;78(8):1035-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16789015</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Evol. 2002 Jun;54(6):807-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12029362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2006 Nov;13(11):715-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17052270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Res. 2009 Feb;39(2):157-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19208036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2009 Jan 28;15(4):423-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19152446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dig Dis. 2016;34(4):293-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27170381</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2001 Nov;52(2):91-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11672818</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2016 Jun;88(6):1035-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26629781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2013 Oct;19:152-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23871776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2008 Jan;80(1):27-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18041043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2017;22(2):97-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27354181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2016 Dec 19;16(1):761</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27993129</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Res. 2010 Jan;40(1):14-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20156297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Evol. 2016 Jul;33(7):1870-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27004904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2004 May;85(Pt 5):1211-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15105537</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2012 Jul;40(Web Server issue):W193-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22600739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2014 Dec;29:125-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25449246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2010 Jun;17(6):444-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19780948</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2015 Oct 17;386(10003):1546-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26231459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2010 Feb;91(Pt 2):483-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19812261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2008;51(6):417-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19258721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2003 Apr;69(4):459-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12601751</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Res. 2007 Jul;37(s1):S9-S19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17627641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2006;78 Suppl 1:S36-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16622876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2004 Jul 15;190(2):400-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15216479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2003 Aug;70(4):529-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12794714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2013 Jul 18;13:328</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23865777</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2007 Dec;47(6):760-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17928090</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Biochem. 2003 Jul;270(14):2929-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12846825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2002 Jan;40(1):22-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11773087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Genes. 2013 Dec;47(3):448-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24006120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2005 Sep;12(5):456-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16108759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trans R Soc Trop Med Hyg. 2015 Nov;109(11):723-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26386408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W654-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15215470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2007;50(1):45-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17164557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2016 Aug 11;16(1):769</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27514515</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">29016603</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>10</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2017</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0181643</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0181643</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hepatitis B Virus (HBV) infection is a worldwide public health problem. In the 1980's a highly effective and safe vaccine against HBV was developed, although breakthrough infection still occasionally occurs because of the emergence of escape mutants. The aim of this study was to identify HBV genotypes and escape mutants in children and their mothers in Amerindian communities of the Amazonas State, Southern Colombia.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Blood specimens collected from children and mothers belonging to 37 Amerindian communities in Amazonas state, were screened for HBsAg and anti-HBc using ELISA. The partial region containing the S ORF was amplified by nested PCR, and amplicons were sequenced. The phylogenetic analysis was performed using the MEGA 5.05 software.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-six children (46/1275, 3.6%) and one hundred and seventy-seven mothers (177/572, 30.9%) were tested positive for the anti-HBc serological marker. Among them, 190 samples were tested for viral genome detection; 8.3% (2/31) serum samples obtained from children and 3.1% (5/159) from mothers were positive for the ORF S PCR. The predominant HBV genotype in the study population was F, subgenotype F1b; in addition, subgenotype F1a and genotype A were also characterized. Two HBV escape mutants were identified, G145R, reported worldwide, and W156*; this stop codon was identified in a child with occult HBV infection. Other mutations were found, L109R and G130E, located in critical positions of the HBsAg sequence.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study aimed to characterize the HBV genotype F, subgenotypes F1b and F1a, and genotype A in Amerindian communities and for the first time escape mutants in Colombia. Further investigations are necessary to elucidate the frequency and the epidemiological impact of the escape mutants in the country.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jaramillo</LastName>
                    <ForeName>Carlos Mario</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Grupo de Gastrohepatologia, Facultad de Medicina, Universidad de Antioquia, UdeA, Medellin, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de La Hoz</LastName>
                    <ForeName>Fernando</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Grupo de Epidemiologia y Evaluaci√≥n en Salud P√∫blica, Universidad Nacional, Bogota, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Porras</LastName>
                    <ForeName>Alexandra</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Grupo de Epidemiologia y Evaluaci√≥n en Salud P√∫blica, Universidad Nacional, Bogota, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>di Filippo</LastName>
                    <ForeName>Diana</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Grupo de Gastrohepatologia, Facultad de Medicina, Universidad de Antioquia, UdeA, Medellin, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choconta-Piraquive</LastName>
                    <ForeName>Luz Angela</ForeName>
                    <Initials>LA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Grupo de Epidemiologia y Evaluaci√≥n en Salud P√∫blica, Universidad Nacional, Bogota, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Payares</LastName>
                    <ForeName>Edra</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratorio Departamental de Salud Publica del Amazonas, Leticia, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Montes</LastName>
                    <ForeName>Neyla</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Coordinacion Salud Publica, Alcaldia de Puerto Nari√±o, Puerto Nari√±o, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Navas</LastName>
                    <ForeName>Maria-Cristina</ForeName>
                    <Initials>MC</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2610-9306</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Grupo de Gastrohepatologia, Facultad de Medicina, Universidad de Antioquia, UdeA, Medellin, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007198" MajorTopicYN="N">Indians, North American</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009035" MajorTopicYN="N">Mothers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010802" MajorTopicYN="Y">Phylogeny</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>07</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">29016603</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0181643</ArticleId>
            <ArticleId IdType="pii">PONE-D-16-44596</ArticleId>
            <ArticleId IdType="pmc">PMC5634536</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Hepat Res Treat. 2011;2011:363205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21941645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2005 Dec;34 Suppl 2:S8-S13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16461245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2004 Mar;72(3):377-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14748061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2011 Jul;63(1):66-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21640384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 May;49(5 Suppl):S13-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19399811</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2010 Aug 2;28(34):5605-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20598405</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2011 Jan;11(1):103-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20951841</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2008 Jan;80(1):20-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18041024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ISRN Gastroenterol. 2012;2012:960413</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23029621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2011 Sep;83(9):1530-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21739442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2012 Oct 24;9:244</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23092209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2012 Apr;86(8):4658-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22301154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2001 Feb;82(Pt 2):359-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11161274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2008 Mar;12(2):183-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17913535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2015 Oct;53(10):3165-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26202119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2008 Jul;48(1):88-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18537180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2010 Jan;84(2):1026-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19889778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2005 Jun;76(2):161-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15834887</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Agents Dis. 1994 Aug;3(4):201-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7827789</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2010 Feb;91(Pt 2):501-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19846674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2007 Aug;127(2):177-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17280734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2006 Jan;78(1):24-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16299725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2011 Mar 28;17(12):1543-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21472118</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Microbiol. 2007 Nov 23;7:103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18036224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2001 Jul;64(3):356-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11424126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2010 Apr 15;201(8):1192-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20210630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2012 Oct;19(10):754-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22967107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2009 Sep;83(18):9321-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19570861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2013;18(3 Pt B):459-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23792558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2015 Oct 24;12:172</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26497287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2011 Mar 28;17(12):1563-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21472122</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Trop Med Hyg. 2005 Oct;73(4):808-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16222030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2008;13(7):875-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19043921</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trop Med Int Health. 2005 Apr;10(4):322-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15807795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Health Serv Res. 2016 Jul 21;16:293</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27443313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2003 Oct;60(2):75-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14638401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 1997;4 Suppl 1:11-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9097273</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2011 Aug;11(6):1462-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21645647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2012 Aug;84(8):1177-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22711345</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2004 Oct;53(10):1499-503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15361503</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2006 May;36 Suppl 1:S45-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16831693</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2014 Feb 21;14:94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24555665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1990 Aug 11;336(8711):325-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1697396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2010 Jul;87(1):74-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20403388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pathol Biol (Paris). 2010 Aug;58(4):288-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20382485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2005 Dec;34 Suppl 1:S125-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16461211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Immunopathol. 2013 Jan;35(1):39-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22829332</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Virol. 2008;153(10):1885-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18813870</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">28939157</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>03</Month>
            <Day>09</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>04</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>35</Volume>
                    <Issue>43</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>10</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.</ArticleTitle>
            <Pagination>
                <MedlinePgn>5808-5813</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(17)31251-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2017.09.030</ELocationID>
            <Abstract>
                <AbstractText>Hepatitis B vaccine escape variants are the main threat to hepatitis B virus (HBV) infection in vaccination era worldwide. With 215 genotype B HBV and 313 genotype C HBV vaccine escape variants isolated from China during 2000-2016, we reported that genotype B HBV vaccine escape strains diverged in ‚àº1997 (95% HPD; 1987-2005), while genotype C HBV vaccine escape strains diverged in ‚àº1976 (95% HPD; 1955-2003). Additionally, the p-distance of genotype C HBV vaccine escape strains was 0.0291¬±0.0169, which was significantly higher than that in the genotype B HBV (t=131.02, p&lt;0.05). However, genotype B HBV vaccine escape strains evolved more rapidly than genotype C HBV (2.103√ó10<sup>-3</sup> vs 1.083√ó10<sup>-3</sup> substitutions/site/year). Bayesian skyline plot analysis showed that the populations of genotype C HBV vaccine escape strains fluctuated more than those in genotype B HBV. Four sites (A5T/S, L21S, T/A126S and T/N131I/A) and 13 sites (N3S, T5A, G10Q/R/E, L21S, T47K/A/V, L98V/P, I/S126N/V/T, Q129H/R/L, T131P/I/N/A, G145A/R, L175S/F, L213I/S, V224A/G) were found to be under positive selection in genotype B and C HBV vaccine escape strains, respectively. More importantly, N3S, L21S, T47K, L98V, I/S126T and L213I mutations were detected in 1 (2.5%), 1 (2.5%), 1 (2.5%), 3 (7.5%), 1 (2.5%), 1 (2.5%) genotype C HBV infected Chinese younger with neonatal HBV vaccination, respectively. Therefore, our results should be valuable in further understanding the molecular evolution of HBV and providing new ideas for the elimination of HBV infection.</AbstractText>
                <CopyrightInformation>Copyright ¬© 2017 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Statistics, School of Public Health, Jiangsu Key Laboratory and Translational Medicine for Geriatric Disease, Medical College of Soochow University, Suzhou, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qiu</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Statistics, School of Public Health, Jiangsu Key Laboratory and Translational Medicine for Geriatric Disease, Medical College of Soochow University, Suzhou, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Yinwei</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Statistics, School of Public Health, Jiangsu Key Laboratory and Translational Medicine for Geriatric Disease, Medical College of Soochow University, Suzhou, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Industrial Park Centers for Disease Control and Prevention, Suzhou 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Lugang</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Industrial Park Centers for Disease Control and Prevention, Suzhou 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Industrial Park Centers for Disease Control and Prevention, Suzhou 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Lige</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Statistics, School of Public Health, Jiangsu Key Laboratory and Translational Medicine for Geriatric Disease, Medical College of Soochow University, Suzhou, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guo</LastName>
                    <ForeName>Zhirong</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Statistics, School of Public Health, Jiangsu Key Laboratory and Translational Medicine for Geriatric Disease, Medical College of Soochow University, Suzhou, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Chen</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Statistics, School of Public Health, Jiangsu Key Laboratory and Translational Medicine for Geriatric Disease, Medical College of Soochow University, Suzhou, Jiangsu, China. Electronic address: cdong@suda.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>09</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017325">Hepatitis B Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017325" MajorTopicYN="N">Hepatitis B Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Hepatitis B virus</Keyword>
            <Keyword MajorTopicYN="Y">Molecular evolution</Keyword>
            <Keyword MajorTopicYN="Y">Mutations</Keyword>
            <Keyword MajorTopicYN="Y">Vaccine escape</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>06</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2017</Year>
                <Month>09</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>09</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>3</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28939157</ArticleId>
            <ArticleId IdType="pii">S0264-410X(17)31251-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2017.09.030</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">26755866</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>01</Month>
            <Day>17</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2219-2840</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>22</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Jan</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>World journal of gastroenterology</Title>
                <ISOAbbreviation>World J. Gastroenterol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Overview of hepatitis B virus mutations and their implications in the management of infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>145-54</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v22.i1.145</ELocationID>
            <Abstract>
                <AbstractText>Hepatitis B virus (HBV) affects approximately two billion people worldwide and more than 240 million people in the world are currently chronic carrier that could develop serious complications in the future, like liver cirrhosis and hepatocellular carcinoma. Although an extended HBV immunization program is being carried out since the early '80s, representing effective preventive measure, leading to a dramatic reduction of HBV hepatitis incidence, globally HBV infection still represents a major public health problem. The HBV virus is a DNA virus belongs to the Hepadnaviridae family. The HBV-DNA is a circular, partial double strand genome. All coding information is on the minus DNA strand and it is organized into four open reading frames. Despite hepatitis B virus is a DNA virus, it has a high mutation rate due to its replicative strategy, that leads to the production of many non-identical variants at each cycle of replication. In fact, it contains a polymerase without the proofreading activity, and uses an RNA intermediate (pgRNA) during its replication, so error frequencies are comparable to those seen in retroviruses and other RNA viruses rather than in more stable DNA viruses. Due to the low fidelity of the polymerase, the high replication rate and the overlapping reading frames, mutations occur throughout the genome and they have been identified both in the structural and not structural gene. The arise of mutations being to develop of a whole of viral variants called &quot;quasi-species&quot; and the prevalent population, which favors virus replication, was selected by viral fitness, host's immune pressure and external pressure, i.e., vaccination or antiviral therapy. Naturally occurring mutations were found both in acute and chronic subjects. In the present review we examine and discuss the most recent available data about HBV genetic variability and its significance. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Caligiuri</LastName>
                    <ForeName>Patrizia</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Patrizia Caligiuri, Giancarlo Icardi, Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cerruti</LastName>
                    <ForeName>Rita</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Patrizia Caligiuri, Giancarlo Icardi, Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Icardi</LastName>
                    <ForeName>Giancarlo</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Patrizia Caligiuri, Giancarlo Icardi, Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bruzzone</LastName>
                    <ForeName>Bianca</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Patrizia Caligiuri, Giancarlo Icardi, Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World J Gastroenterol</MedlineTA>
            <NlmUniqueID>100883448</NlmUniqueID>
            <ISSNLinking>1007-9327</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hepatitis B virus</Keyword>
            <Keyword MajorTopicYN="N">Liver disease</Keyword>
            <Keyword MajorTopicYN="N">Molecular biology tools</Keyword>
            <Keyword MajorTopicYN="N">Mutations</Keyword>
            <Keyword MajorTopicYN="N">Open reading frames</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>05</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2015</Year>
                <Month>08</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2015</Year>
                <Month>12</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>1</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>1</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>1</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">26755866</ArticleId>
            <ArticleId IdType="doi">10.3748/wjg.v22.i1.145</ArticleId>
            <ArticleId IdType="pmc">PMC4698481</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Viral Hepat. 1999 Nov;6(6):415-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10607259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol. 2004 Jan;39(1):34-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14767732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepat Mon. 2015 Feb 21;15(2):e23875</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25788956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepat Mon. 2014 May 03;14(5):e15275</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24829588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Genet Med. 1992;2:67-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1333869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2006 May;26(2):87-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16673287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2007 Nov 15;196(10):1483-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18008227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2015 Mar;61(3):823-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25418031</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2007 Feb;132(2):543-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17258721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Sci. 2006 Aug;97(8):683-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16863502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2013 Dec;51(12):3928-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24025913</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tumour Biol. 2014 Oct;35(10):10325-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25034530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2013 Jun 28;19(24):3861-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23840126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2009 Nov;137(5):1593-608.e1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19737565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2004;47(6):289-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15564741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1999 Mar;29(3):946-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10051502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2014 Jun 28;20(24):7707-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24976708</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2015 Jun;87(6):993-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25712861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Exp Hepatol. 2012 Dec;2(4):353-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25755457</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 2011 Jan 30;412(3-4):305-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21056552</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Oct;57(4):720-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22634131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2009 Dec 14;15(46):5761-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19998495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2006;78 Suppl 1:S52-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16622878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2007 Nov;14 Suppl 1:11-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17958637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2008 Jul;48(1):88-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18537180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2008 Aug 20;100(16):1134-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18695135</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2013 Jan;20(1):42-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23231083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2013 Mar;57(3):934-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23112104</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Immunol. 1986 May;23(5):511-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3748012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Carcinogenesis. 2008 Jan;29(1):106-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17999990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2007 Nov;14 Suppl 1:16-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17958638</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2014 Feb;59(2):434-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23939953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2012 Sep;84(9):1340-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22825811</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2014 Jun 28;20(24):7653-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24976703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2014 May 14;20(18):5435-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24833874</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 1989 Jun;170(2):595-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2728351</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2008 Sep;103(9):2254-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18844615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2009 Jan 14;23(2):268-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19098499</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2011;11:398</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21933446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformation. 2013;9(3):121-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23423477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2008;13(7):875-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19043921</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2008 Apr;80(4):598-602</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18297712</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2007 Jan 7;13(1):82-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17206757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2012 Jan;93(1):86-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22086128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Jul;57(1):167-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22436845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2008 Apr;61(4):766-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18218641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 May;49(5):1503-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19280622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2014 May 21;20(19):5708-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24914332</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2007 Nov;133(5):1466-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17915220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Hepatol. 2015 Mar 27;7(3):289-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25848459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Feb;124(2):327-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12557138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatobiliary Surg Nutr. 2015 Feb;4(1):1-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25713800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):590-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19190166</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2012 Jan;163(1):197-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21963662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2008 Jan;57(1):91-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17502344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1993 Jan 15;268(2):1332-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8419335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1988 Nov 12;2(8620):1132-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2460710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 Jun;49(6):1962-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19475690</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dig Dis Sci. 2015 May;60(5):1315-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25567052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2004 Dec;78(23):12725-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15542625</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2006 May;26(2):162-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16673294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2010 Feb;48(2):357-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19940057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2012 Aug;56(2):422-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22105832</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2014 Jun 28;20(24):7622-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24976700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2006 Apr;130(4):1153-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16618410</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015;10(3):e0120733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25822176</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2013 Oct;67(4):303-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23796863</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25483515</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>12</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2164-554X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2015</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Human vaccines &amp; immunotherapeutics</Title>
                <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hepatitis B vaccination.</ArticleTitle>
            <Pagination>
                <MedlinePgn>53-7</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4161/hv.34306</ELocationID>
            <Abstract>
                <AbstractText>Hepatitis B virus is a worldwide leading cause of acute and chronic liver disease including cirrhosis and hepatocellular carcinoma. Effective vaccines have been available since the early '80s and vaccination has proved highly successful in reducing the disease burden, the development of the carrier state and the HB-related morbidity and mortality in the countries where vaccination has been implemented.   Neutralizing (protective) antibodies (anti-HBs) induced by vaccination are targeted largely towards the amino acid hydrophilic region, referred to as the common a determinant which is present on the outer protein coat or surface antigen (HBsAg), spanning amino acids 124-149. This provides protection against all HBV genotypes (from A to H) and is responsible for the broad immunity afforded by hepatitis B vaccination. Thus, alterations of residues within this region of the surface antigen may determine conformational changes that can allow replication of the mutated HBV in vaccinated people. An important mutation in the surface antigen region was identified in Italy some 25 years ago in infants born to HBsAg carrier mothers who developed breakthrough infections despite having received HBIG and vaccine at birth. This virus had a point mutation from guanosine to adenosine at nucleotide position 587, resulting in aa substitution from glycine (G) to arginine (R) at position 145 in the a determinant. Since the G145R substitution alters the projecting loop (aa 139-147) of the a determinant, the neutralizing antibodies induced by vaccination are no longer able to recognize the mutated epitope. Beside G145R, other S-gene mutations potentially able to evade neutralizing anti-HBs and infect vaccinated people have been described worldwide. In addition, the emergence of Pol mutants associated with resistance to treatment with nucleos(t)ide analogues can select viruses with crucial changes in the overlapping S-gene, potentially able to alter the S protein immunoreactivity. Thus such mutants have the potential to infect both na√Øve and immunized people, negatively affecting the efficacy of both the antiviral treatment and the vaccination programs. Despite concern, at present the overall impact of vaccine escapes mutants seems to be low and they do not pose a public health threat or a need to modify the established hepatitis B vaccination programs. The development of novel NAs with a high barrier to resistance is warranted. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Roman√≤</LastName>
                    <ForeName>Luisa</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>a Dipartimento di Scienze Biomediche per la Salute; Universit√† degli Studi di Milano; Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paladini</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galli</LastName>
                    <ForeName>Cristina</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raimondo</LastName>
                    <ForeName>Giovanni</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pollicino</LastName>
                    <ForeName>Teresa</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zanetti</LastName>
                    <ForeName>Alessandro R</ForeName>
                    <Initials>AR</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>11</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Vaccin Immunother</MedlineTA>
            <NlmUniqueID>101572652</NlmUniqueID>
            <ISSNLinking>2164-5515</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006510">Hepatitis B Antibodies</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017325">Hepatitis B Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006510" MajorTopicYN="N">Hepatitis B Antibodies</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017325" MajorTopicYN="N">Hepatitis B Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057131" MajorTopicYN="N">Immune Evasion</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007558" MajorTopicYN="N">Italy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">HBV</Keyword>
            <Keyword MajorTopicYN="N">HBV escape mutants</Keyword>
            <Keyword MajorTopicYN="N">Hepatitis B</Keyword>
            <Keyword MajorTopicYN="N">Hepatitis B vaccination</Keyword>
            <Keyword MajorTopicYN="N">drug resistant mutants</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>12</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25483515</ArticleId>
            <ArticleId IdType="doi">10.4161/hv.34306</ArticleId>
            <ArticleId IdType="pmc">PMC4514213</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Intervirology. 2004;47(6):289-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15564741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1990 Aug 11;336(8711):325-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1697396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2009 Dec 1;286(1):80-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19683385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2010 Apr 15;201(8):1192-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20210630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2010 Nov;14(11):e941-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20674432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2012 Apr;12(4):341-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22326017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Jul;57(1):167-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22436845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Oct;57(4):730-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22668640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2013 Nov;87(22):12196-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24006443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2014 Apr;88(8):4605-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24672049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 1992 Feb;36(2):101-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1583465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1995 Mar;21(3):884-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7875688</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1995 Jun 3;345(8962):1406-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7539089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1997 Mar;175(3):511-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9041321</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1997 Sep;26(3):786-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9303514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1998 Jan;27(1):254-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9425945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transfusion. 1998 Jan;38(1):56-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9482395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 1999 Sep;59(1):19-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10440803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2014 Jun;88(11):6532</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24803487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2014 Aug;61(2):408-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24801416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2005 Jul;54(7):1009-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15951551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2007 Apr 20;25(16):3133-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17280750</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2008 Oct 2;359(14):1486-500</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18832247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2008 Nov 18;26(49):6266-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18848855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2009 Feb 14;373(9663):582-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19217993</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2009 Oct 7;101(19):1348-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19759364</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2009 Nov;137(5):1593-608.e1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19737565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10704474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2000 Apr 22;355(9213):1382-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10791517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2002 Nov;68(3):319-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12226817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2004 Oct;53(10):1499-503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15361503</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1982 Jan;79(2):579-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6176997</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1988 Nov 12;2(8620):1132-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2460710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2005 Mar;12(2):111-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15720525</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20382061</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>02</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2010</Year>
            <Month>10</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-3511</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14 Suppl 3</Volume>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title>
                <ISOAbbreviation>Int. J. Infect. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e136-41</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2009.11.039</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The hepatitis B virus (HBV) polymerase gene completely overlaps with the envelope gene. In the present study we aimed to monitor the prevalence and pattern of the typical mutations for hepatitis B surface antigen (HBsAg) escape, and concomitantly nucleos(t)ide analog (NUC) resistance mutations, in Turkish patients undergoing different antiviral therapies and in treatment-na√Øve patients with chronic hepatitis B (CHB).</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The investigation was undertaken between March 2007 and August 2009 and involved a total of 142 patients under NUC therapy (88 males; mean age 42 years (range 13-68); hepatitis B e antigen (HBeAg) negativity in 94 patients; HBV DNA median log 4.3 log(10) IU/ml (range 2.0-&gt;6.0); alanine aminotransferase (ALT) median level 76.1 IU/ml (range 12-1082)) and 185 treatment-na√Øve CHB patients (120 males; mean age 39 years (range 1-76 years); HBeAg negativity in 132 patients; HBV DNA median log 3.5 log(10) IU/ml (range 2.0-6.0); ALT median level 60.7 IU/l (range 8-874)).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The overall prevalence of typical HBsAg escape mutations found in the CHB patients was 8.3% (27/327). In the NUC therapy group the prevalence was 8.5% (12/142), with the following patterns: sY100C+sI110V, sL109I, sP120T, sP127T, sG130R+sG145X, sS132A+sY134N, sY134N+sG145R, sC137G, sD144E, sG145R. In the treatment-na√Øve group the prevalence was 8.1% (15/185), with the following patterns: sL109I, sI110V, sS117INST, sP120T, sP127T, sM133I, sC137L+sG145R, sS143L. However, NUC resistance mutations were found in 7.7% (11/142) of the patients on NUC therapy and 3.8% (7/185) of the treatment-na√Øve group patients. Interestingly, the treatment-na√Øve patients had preexisting drug resistance mutations related to lamivudine (rtL180M+rtM204I), adefovir (rtA181V, rtQ215S, rtI233V), entecavir (intermediate susceptibility with rtL180M+rtM204IHBV variant), telbivudine (rtL180M+rtM204I), and tenofovir (rtA194T).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The findings of this study show preexisting typical HBsAg escape and NUC resistance mutations are possible. The genetic arrangement of the HBV genome with polymerase and surface genes overlapping has substantial public health and diagnostic implications and relevance.</AbstractText>
                <CopyrightInformation>Copyright ¬© 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sayan</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Laboratory, PCR Unit, Faculty of Medicine, University of Kocaeli, ƒ∞zmit-Kocaeli, Turkey. sayanmurat@hotmail.com</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sent√ºrk</LastName>
                    <ForeName>O</ForeName>
                    <Initials>O</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Akhan</LastName>
                    <ForeName>S √á</ForeName>
                    <Initials>S√á</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>H√ºlag√º</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cekmen</LastName>
                    <ForeName>M B</ForeName>
                    <Initials>MB</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2010</Year>
                <Month>04</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>Int J Infect Dis</MedlineTA>
            <NlmUniqueID>9610933</NlmUniqueID>
            <ISSNLinking>1201-9712</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015684">Gene Products, pol</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009705">Nucleosides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009711">Nucleotides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C066027">P protein, Hepatitis B virus</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015684" MajorTopicYN="N">Gene Products, pol</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005814" MajorTopicYN="N">Genes, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009705" MajorTopicYN="N">Nucleosides</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009711" MajorTopicYN="N">Nucleotides</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2009</Year>
                <Month>08</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2009</Year>
                <Month>10</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2009</Year>
                <Month>11</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>4</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>4</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>2</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20382061</ArticleId>
            <ArticleId IdType="pii">S1201-9712(10)02311-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ijid.2009.11.039</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">29740207</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>10</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2219-2840</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>24</Volume>
                    <Issue>17</Issue>
                    <PubDate>
                        <Year>2018</Year>
                        <Month>May</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>World journal of gastroenterology</Title>
                <ISOAbbreviation>World J. Gastroenterol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-na√Øve chronic hepatitis B: A case report and review of the literature.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1919-1924</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v24.i17.1919</ELocationID>
            <Abstract>
                <AbstractText>Tenofovir disoproxil fumarate (TDF) is a potent nucleotide analogue that is recommended as first-line therapy for patients with chronic hepatitis B. The results of a longitudinal study of TDF treatment demonstrated no development of resistance. We observed one treatment-na√Øve chronic hepatitis B (CHB) patient who developed TDF resistance after complete viral suppression during long-term TDF treatment. A 37-year-old HBeAg-positive man received TDF 300 mg/d for 43 mo. The hepatitis B virus (HBV) DNA titer was 8 log<sub>10</sub> copies/mL at baseline and became undetectable at 16 mo after treatment. However, the HBV DNA titer rebounded to 7.5 log<sub>10</sub> copies/mL at 43 mo after treatment. We performed full sequencing to find mutation sites associated with virologic breakthrough. The results showed 9 mutation sites, most of which had not been well-known as mutation sites. We changed the therapy from tenofovir to entecavir with a regimen of 0.5 mg once daily. After 4 mo, the HBV DNA titer decreased to 267 copies/mL, and the liver enzyme levels were normalized.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>Woo Hee</ForeName>
                    <Initials>WH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Dankook University College of Medicine, Cheonan 31116, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Hyun Jae</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Dankook University College of Medicine, Cheonan 31116, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bang</LastName>
                    <ForeName>Ki Bae</ForeName>
                    <Initials>KB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Dankook University College of Medicine, Cheonan 31116, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Seok Bae</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Dankook University College of Medicine, Cheonan 31116, South Korea. 11961019@dankook.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Il Han</ForeName>
                    <Initials>IH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Dankook University College of Medicine, Cheonan 31116, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World J Gastroenterol</MedlineTA>
            <NlmUniqueID>100883448</NlmUniqueID>
            <ISSNLinking>1007-9327</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006513">Hepatitis B e Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5968Y6H45M</RegistryNumber>
                <NameOfSubstance UI="C413685">entecavir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5Z93L87A1R</RegistryNumber>
                <NameOfSubstance UI="D006147">Guanine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>99YXE507IL</RegistryNumber>
                <NameOfSubstance UI="D000068698">Tenofovir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057915" MajorTopicYN="N">Drug Substitution</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006513" MajorTopicYN="N">Hepatitis B e Antigens</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008111" MajorTopicYN="N">Liver Function Tests</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000068698" MajorTopicYN="N">Tenofovir</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chronic hepatitis B</Keyword>
            <Keyword MajorTopicYN="N">Mutation</Keyword>
            <Keyword MajorTopicYN="N">Resistance</Keyword>
            <Keyword MajorTopicYN="N">Tenofovir</Keyword>
        </KeywordList>
        <CoiStatement>Conflict-of-interest statement: All authors declare no conflicts of interest related to this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>03</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">29740207</ArticleId>
            <ArticleId IdType="doi">10.3748/wjg.v24.i17.1919</ArticleId>
            <ArticleId IdType="pmc">PMC5937209</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Hepatology. 2007 Feb;45(2):507-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17256718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2006 Dec 1;194(11):1471-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17083029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2002 May 30;346(22):1682-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12037146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 Sep;50(3):661-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19714720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2014 Jul;60(3):313-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24836314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2013 Jul;58(1):98-107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23213040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2000 Oct;32(4 Pt 1):866-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11003636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Oct 7;351(15):1521-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15470215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2005;10(6):727-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16218172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2014 Feb;59(2):434-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23939953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2017 Jan;24(1):68-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27658343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2008 Feb;134(2):405-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18242209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Oct;45(4):529-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16879891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2006 Jul;50(7):2471-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16801428</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Jul;57(1):167-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22436845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 May;49(5):1503-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19280622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Mar 9;354(10):1001-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16525137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2015 Oct 17;386(10003):1546-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26231459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dig Dis Sci. 2012 Nov;57(11):3011-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23010744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2007 Mar;46(3):531-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17239478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 May;49(5 Suppl):S174-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19399794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2012 Dec 21;18(47):6996-7002</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23322999</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Dec;125(6):1714-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14724824</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">29713126</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>09</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2219-2840</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>24</Volume>
                    <Issue>16</Issue>
                    <PubDate>
                        <Year>2018</Year>
                        <Month>Apr</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>World journal of gastroenterology</Title>
                <ISOAbbreviation>World J. Gastroenterol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1708-1724</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v24.i16.1708</ELocationID>
            <Abstract>
                <AbstractText>The annual number of deaths caused by hepatitis B virus (HBV)-related disease, including cirrhosis and hepatocellular carcinoma (HCC), is estimated as 887000. The reported prevalence of HBV reverse transcriptase (RT) mutation prior to treatment is varied and the impact of preexisting mutations on the treatment of na√Øve patients remains controversial, and primarily depends on geographic factors, HBV genotypes, HBeAg serostatus, HBV viral loads, disease progression, intergenotypic recombination and co-infection with HIV. Different sensitivity of detection methodology used could also affect their prevalence results. Several genotype-dependent HBV RT positions that can affect the emergence of drug resistance have also been reported. Eight mutations in RT (rtL80I, rtD134N, rtN139K/T/H, rtY141F, rtM204I/V, rtF221Y, rtI224V, and rtM309K) are significantly associated with HCC progression. HBeAg-negative status, low viral load, and genotype C infection are significantly related to a higher frequency and prevalence of preexisting RT mutations. Preexisting mutations are most frequently found in the A-B interdomain of RT which overlaps with the HBsAg &quot;a&quot; determinant region, mutations of which can lead to simultaneous viral immune escape. In conclusion, the presence of baseline RT mutations can affect drug treatment outcomes and disease progression in HBV-infected populations via modulation of viral fitness and host-immune responses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Yu-Min</ForeName>
                    <Initials>YM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Biomedical Sciences, Liver Research Institute and Cancer Research Institute, Seoul National University, College of Medicine, Seoul 110799, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>So-Young</ForeName>
                    <Initials>SY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Biomedical Sciences, Liver Research Institute and Cancer Research Institute, Seoul National University, College of Medicine, Seoul 110799, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Bum-Joon</ForeName>
                    <Initials>BJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Biomedical Sciences, Liver Research Institute and Cancer Research Institute, Seoul National University, College of Medicine, Seoul 110799, South Korea. kbumjoon@snu.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World J Gastroenterol</MedlineTA>
            <NlmUniqueID>100883448</NlmUniqueID>
            <ISSNLinking>1007-9327</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018894">Reverse Transcriptase Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059645" MajorTopicYN="N">Mutation Rate</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018894" MajorTopicYN="N">Reverse Transcriptase Inhibitors</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hepatitis B virus</Keyword>
            <Keyword MajorTopicYN="N">Hepatocellular carcinoma</Keyword>
            <Keyword MajorTopicYN="N">Polymerase</Keyword>
            <Keyword MajorTopicYN="N">Preexisting mutations</Keyword>
            <Keyword MajorTopicYN="N">Reverse transcriptase</Keyword>
        </KeywordList>
        <CoiStatement>Conflict-of-interest statement: There was no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>03</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>9</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">29713126</ArticleId>
            <ArticleId IdType="doi">10.3748/wjg.v24.i16.1708</ArticleId>
            <ArticleId IdType="pmc">PMC5922991</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Oct 25;7(43):70264-70275</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27602500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 1997 Oct;113(4):1258-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9322520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Ther. 2007 Dec;29(12):2635-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18201580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2015 Mar;96(Pt 3):663-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25481755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2014 Aug;61(2):408-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24801416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2007 Dec;14(12):835-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18070286</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Res Hum Retroviruses. 2007 Apr;23(4):525-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17506609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol. 2004 Jan;39(1):34-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14767732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Dec;44(6):1656-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17133475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2009 Jul 7;15(25):3099-105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19575488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Braz J Infect Dis. 2012 May-Jun;16(3):250-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22729192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Med Rep. 2017 May;15(5):3292-3300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28339094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2002 Aug;37(2):259-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12127432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2007 Sep;14(9):661-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17697019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Jul 30;8(7):e70169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23936156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2007 Apr;81(8):3992-4001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17267485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2005 Feb 14;11(6):867-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15682483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1150-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19785624</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2005 Mar 31;23(19):2409-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15752827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Jul;46(1):254-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17596850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Gastroenterol Hepatol. 2011 May;8(5):275-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21423260</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2006 Jul;13(7):427-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16792535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2014 May 14;20(18):5427-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24833873</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2015 Jan 10;385(9963):117-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25530442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2002 Aug;36(2):464-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12143057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2014 Jun;88(12):6805-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24696492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2011 Jul;18(7):e212-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21692935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepat Mon. 2013 Jan 20;13(1):e6712</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23596461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Braz J Infect Dis. 2016 Mar-Apr;20(2):173-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26876337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Mar;44(3):593-606</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16455151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Clin North Am. 2010 Sep;24(3):809-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20674805</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2012 Dec 28;18(48):7149-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23326119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Jpn J Infect Dis. 2017 Nov 22;70(6):647-655</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29093313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2016 Jan 7;22(1):145-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26755866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Sci Monit. 2017 Nov 02;23 :5230-5236</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29095799</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Exp Hepatol. 2012 Dec;2(4):353-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25755457</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liver Int. 2012 Nov;32(10):1535-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22882650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2001 May;120(6):1564-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11339239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2017;22(1):13-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27167598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2017 Mar 30;18(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28358313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2011 Sep 30;11:262</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21961963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Clin Exp Med. 2017 Oct;26(7):1123-1129</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29211361</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2005 Aug;129(2):528-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16083710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacotherapy. 2009 Oct;29(10):1212-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19792994</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2000 Mar;118(3):554-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10702206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2006 Jan;78(1):24-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16299725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1983 Nov 12;2(8359):1099-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6138642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2012 Oct;18(10):E412-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22827722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 May 01;9(5):e94864</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24788140</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2007 Nov;79(11):1650-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17854040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2001 May;39(5):1972-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11326026</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2001 Mar;33(3):751-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11230757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2012 Feb;84(2):207-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22170539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Feb 27;348(9):808-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12606735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(4):e35052</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22523569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Drug Resist. 2017 Dec 14;10 :507-509</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29276396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2005 May;43(5):2503-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15872296</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2006 Dec;21(12):1783-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17074014</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Gastroenterol Hepatol. 2013 Jul;25(7):814-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23406845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2010 Dec;88(3):269-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20875460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2015;20(2):141-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24992206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2002 Jun;76(12):5985-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12021331</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2012 May;54(1):66-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22398037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2002 Dec 14;360(9349):1921-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12493258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2007 Jan 7;13(1):14-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17206751</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2014 Aug;12(8):1363-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24342744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2013 Feb 14;10:56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23409946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2006 Sep 7;12(33):5301-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16981258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2012 May 25;427(1):51-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22374235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2005 Mar;5(3):215-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15738952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2017 Jun 21;23 (23 ):4222-4232</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28694662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2011 Nov;92(2):382-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21920388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Turk J Gastroenterol. 2008 Jun;19(2):99-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19110664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2013 Jul;85(7):1155-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23918533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2009 Jun;81(6):996-1001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19382250</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2009 Mar;50(3):461-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19041149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Dec 29;12 (12 ):e0189730</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29287068</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Mar 30;10(3):e0117429</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25821965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2002 Nov;68(3):311-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12226816</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2006 Aug;87(Pt 8):2203-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16847116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Drug Resist. 2017 Jul 05;10 :201-207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28740410</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2013 Sep;58(3):890-901</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23505208</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Med Microbiol. 2013 Oct-Dec;31(4):360-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24064642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs Today (Barc). 2007 Apr;43(4):201-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17460784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2008 Apr;61(4):766-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18218641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 May;49(5):1503-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19280622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Pharmacol. 1998 May 15;55(10):1567-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9633992</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2003 Sep;38(3):619-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12939588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liver Int. 2005 Apr;25(2):201-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15780040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Apr 27;354(17):1807-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16641397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2012 Dec;96(3):422-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23026293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kobe J Med Sci. 2016 Jun 16;62(1):E1-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27492206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2008 May;12(3):252-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17954033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2010 Mar;85(3):512-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20034521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2009 Aug;24(8):1417-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19486254</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2004 Jan;39(1):64-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14752824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2013 Jan 14;27(2):191-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23032418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2008 Jan;12(1):83-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17698384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2005 Dec;79(24):15467-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16306618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>HIV Med. 2009 Apr;10(4):229-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19178592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Gastroenterol. 2012 Aug 27;12:116</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22925657</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2004 Oct;53(10):1494-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15361502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2009;14 (8):1081-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20032538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2009 Feb;83(4):1718-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19073746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(9):e46345</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23029487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diagn Microbiol Infect Dis. 2014 May;79(1):25-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24630522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2001 Apr;34(4):584-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11394659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2007 Jun;79(6):676-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17457904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2008 Jun;2(2):147-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19669299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2015 Feb;30(2):252-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25318660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2010 Nov;82(11):1850-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20872711</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2013 Oct 28;10:320</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24165277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nan Fang Yi Ke Da Xue Xue Bao. 2014 Oct;34(10):1436-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25345938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2018 Jan;57:26-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29111272</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2009 May 1;199(9):1275-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19301976</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2009;14(5):649-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19704167</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2008 Dec 21;14(47):7231-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19084939</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4398-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8633078</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2001 Oct;65(2):257-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11536231</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2007 Jul;51(7):2285-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17438047</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2012;55(1):36-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21311172</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">29093313</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>07</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>07</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1884-2836</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>70</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Nov</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Japanese journal of infectious diseases</Title>
                <ISOAbbreviation>Jpn. J. Infect. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Profile of Mutations in the Reverse Transcriptase and Overlapping Surface Genes of Hepatitis B Virus (HBV) in Treatment-Na√Øve Indonesian HBV Carriers.</ArticleTitle>
            <Pagination>
                <MedlinePgn>647-655</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.7883/yoken.JJID.2017.078</ELocationID>
            <Abstract>
                <AbstractText>Mutations in the reverse transcriptase (RT) region of the hepatitis B virus (HBV) genome are an important factor in low therapeutic effectiveness. Nonetheless, the prevalence of these mutations in HBV strains isolated previously in Indonesia has not been systematically examined. Therefore, in this study, we investigated the profile of mutations in the RT region and the associations of these mutations with amino acid changes in the surface protein in the virus of treatment-na√Øve Indonesian HBV carriers. Overall, 96 sequences of the full-length Indonesian HBV genomes (genotype B, n = 54; genotype C, n = 42) were retrieved from the National Center for Biotechnology Information. Naturally occurring primary and/or compensatory drug resistance mutations were found in 6/54 (11.1%) genotype B strains and in 1/42 (2.4%) genotype C strains. The potential mutations underlying resistance to a nucleos(t)ide analog and/or pretreatment mutations were more frequent in both genotypes but more frequent in genotype C strains than in genotype B strains. The A-B interdomain region in the RT gene was more frequently mutated in genotype C than in genotype B (3.51 ¬± 2.53 vs. 1.08 ¬± 1.52, P Ôºú 0.001). Knowledge about the mutational profiles of the RT gene and changes in the surface protein may help clinicians to select the most appropriate antiviral drug and vaccination or HBV immunoglobulin regimen for management of HBV infection in Indonesia.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yamani</LastName>
                    <ForeName>Laura Navika</ForeName>
                    <Initials>LN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Tropical Disease, Airlangga University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yano</LastName>
                    <ForeName>Yoshihiko</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Infectious Diseases, Kobe University Graduate School of Medicine.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Kobe University Graduate School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Utsumi</LastName>
                    <ForeName>Takako</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Tropical Disease, Airlangga University.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Infectious Diseases, Kobe University Graduate School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wasityastuti</LastName>
                    <ForeName>Widya</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiology, Dr. Sardjito Hospital, Gadjah Mada University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rinonce</LastName>
                    <ForeName>Hanggoro Tri</ForeName>
                    <Initials>HT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomical Pathology, Faculty of Medicine, Dr. Sardjito Hospital, Gadjah Mada University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Widasari</LastName>
                    <ForeName>Dewiyani Indah</ForeName>
                    <Initials>DI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomical Pathology, Faculty of Medicine, Dr. Sardjito Hospital, Gadjah Mada University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Juniastuti</LastName>
                    <AffiliationInfo>
                        <Affiliation>Institute of Tropical Disease, Airlangga University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lusida</LastName>
                    <ForeName>Maria Inge</ForeName>
                    <Initials>MI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Tropical Disease, Airlangga University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soetjipto</LastName>
                    <AffiliationInfo>
                        <Affiliation>Institute of Tropical Disease, Airlangga University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hayashi</LastName>
                    <ForeName>Yoshitake</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Infectious Diseases, Kobe University Graduate School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>Jpn J Infect Dis</MedlineTA>
            <NlmUniqueID>100893704</NlmUniqueID>
            <ISSNLinking>1344-6304</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002353" MajorTopicYN="Y">Carrier State</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007214" MajorTopicYN="N">Indonesia</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058974" MajorTopicYN="N">Phylogeography</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Indonesia</Keyword>
            <Keyword MajorTopicYN="N">hepatitis B virus (HBV)</Keyword>
            <Keyword MajorTopicYN="N">nucleos(t)ide analog (NA) resistance</Keyword>
            <Keyword MajorTopicYN="N">reverse transcriptase (RT) gene</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>7</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">29093313</ArticleId>
            <ArticleId IdType="doi">10.7883/yoken.JJID.2017.078</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">28581155</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>05</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>08</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1365-2893</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>24</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>11</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of viral hepatitis</Title>
                <ISOAbbreviation>J. Viral Hepat.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1032-1042</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/jvh.12732</ELocationID>
            <Abstract>
                <AbstractText>Antiviral drug resistance hepatitis B virus (HBV) variants (HBV-DR) occur spontaneously in chronic hepatitis B (CHB) patients and after exposure to nucleos(t)ide analogues (NUCs). We determined the prevalence of HBV-DR variants among participants of the Hepatitis B Research Network (HBRN) Cohort Study conducted at 21 sites in the United States (US) and Canada. Samples obtained from 1342 CHB participants aged ‚â•18 years, and who were currently not receiving NUCs, were tested for HBV-DR variants by Sanger sequencing. In addition, next generation sequencing (NGS) was used to characterize HBV-DR variants from 66 participants with and 66 participants with no prior NUC exposure matched for HBV genotype and HBV DNA level. Half the participants were men, 75% Asian, 26% HBeAg positive. Primary HBV-DR variants were detected by Sanger sequencing in 16 (1.2%) participants: 2/142 (1.4%) with and 14/1200 (1.2%) without prior NUC exposure; only 1 of these 16 had a secondary variant. In total, 23 (1.7%) participants had secondary variants, including 1 with prior NUC experience. In the subset of 132 participants, NGS detected HBV-DR variants in a higher proportion of participants: primary variants in 18 (13.6%) (8 [12.1%] with, and 10 [15.2%] without prior NUC therapy) and secondary variants in 10 (7.6%) participants. Based on Sanger sequencing, prevalence of primary HBV-DR variants is low (1.2%) among adults with CHB in US/Canada. The similar low prevalence of HBV-DR variants in participants with and without NUC treatment suggests transmission of these variants is uncommon.</AbstractText>
                <CopyrightInformation>¬© 2017 John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lok</LastName>
                    <ForeName>A S</ForeName>
                    <Initials>AS</Initials>
                    <Identifier Source="ORCID">0000-0002-5811-6845</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ganova-Raeva</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centers for Disease Control and Prevention, Division of Viral Hepatitis Laboratory Branch, Atlanta, GA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cloonan</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Punkova</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centers for Disease Control and Prevention, Division of Viral Hepatitis Laboratory Branch, Atlanta, GA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>H-H S</ForeName>
                    <Initials>HS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>W M</ForeName>
                    <Initials>WM</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ghany</LastName>
                    <ForeName>M G</ForeName>
                    <Initials>MG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Liver Diseases Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>Hepatitis B Research Network (HBRN)</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>GENBANK</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>DK082863</AccessionNumber>
                        <AccessionNumber>DK082864</AccessionNumber>
                        <AccessionNumber>DK082866</AccessionNumber>
                        <AccessionNumber>DK082867</AccessionNumber>
                        <AccessionNumber>DK082871</AccessionNumber>
                        <AccessionNumber>DK082872</AccessionNumber>
                        <AccessionNumber>DK082874</AccessionNumber>
                        <AccessionNumber>DK082919</AccessionNumber>
                        <AccessionNumber>DK082923</AccessionNumber>
                        <AccessionNumber>DK082927</AccessionNumber>
                        <AccessionNumber>DK082943</AccessionNumber>
                        <AccessionNumber>DK082944</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>U01 DK082944</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082872</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 TR000004</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 DK050306</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082943</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082874</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>K24 AA022523</GrantID>
                    <Acronym>AA</Acronym>
                    <Agency>NIAAA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>M01 RR000040</GrantID>
                    <Acronym>RR</Acronym>
                    <Agency>NCRR NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 TR001111</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082864</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082866</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 TR002240</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082923</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082863</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 TR000058</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082843</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 RR024986</GrantID>
                    <Acronym>RR</Acronym>
                    <Agency>NCRR NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082867</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082919</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082927</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 DK082871</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>07</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Viral Hepat</MedlineTA>
            <NlmUniqueID>9435672</NlmUniqueID>
            <ISSNLinking>1352-0504</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009656" MajorTopicYN="N">North America</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Sanger sequencing</Keyword>
            <Keyword MajorTopicYN="Y">antiviral treatment</Keyword>
            <Keyword MajorTopicYN="Y">hepatitis B virus</Keyword>
            <Keyword MajorTopicYN="Y">next generation sequencing</Keyword>
            <Keyword MajorTopicYN="Y">nucleos(t)ide analogues</Keyword>
        </KeywordList>
        <InvestigatorList>
            <Investigator ValidYN="Y">
                <LastName>Lau</LastName>
                <ForeName>Daryl T-Y</ForeName>
                <Initials>DT</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chung</LastName>
                <ForeName>Raymond T</ForeName>
                <Initials>RT</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Roberts</LastName>
                <ForeName>Lewis R</ForeName>
                <Initials>LR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Smith</LastName>
                <ForeName>Coleman I</ForeName>
                <Initials>CI</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Di Bisceglie</LastName>
                <ForeName>Adrian M</ForeName>
                <Initials>AM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>-Melman</LastName>
                <ForeName>Mauricio</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Janssen</LastName>
                <ForeName>L A</ForeName>
                <Initials>LA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wong</LastName>
                <ForeName>David K</ForeName>
                <Initials>DK</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Juan</LastName>
                <ForeName>Joshua</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Feld</LastName>
                <ForeName>Jordan</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Yim</LastName>
                <ForeName>Colina</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Heathcote</LastName>
                <ForeName>Jenny</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Perrillo</LastName>
                <ForeName>Robert</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Do</LastName>
                <ForeName>Son</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Han</LastName>
                <ForeName>Steven-Huy B</ForeName>
                <Initials>SB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tran</LastName>
                <ForeName>Tram T</ForeName>
                <Initials>TT</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Terrault</LastName>
                <ForeName>Norah A</ForeName>
                <Initials>NA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Khalili</LastName>
                <ForeName>Mandana</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cooper</LastName>
                <ForeName>Stewart L</ForeName>
                <Initials>SL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fontana</LastName>
                <ForeName>Robert J</ForeName>
                <Initials>RJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tsai</LastName>
                <ForeName>Naoky</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fried</LastName>
                <ForeName>Michael W</ForeName>
                <Initials>MW</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Patel</LastName>
                <ForeName>Keyur</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Evon</LastName>
                <ForeName>Donna</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Carithers</LastName>
                <ForeName>Robert C</ForeName>
                <Initials>RC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Shuhart</LastName>
                <ForeName>Margaret</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kowdley</LastName>
                <ForeName>Kris V</ForeName>
                <Initials>KV</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wang</LastName>
                <ForeName>Chia C</ForeName>
                <Initials>CC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sterling</LastName>
                <ForeName>Richard K</ForeName>
                <Initials>RK</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jake Liang</LastName>
                <ForeName>T</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hoofnagle</LastName>
                <ForeName>Jay H</ForeName>
                <Initials>JH</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Doo</LastName>
                <ForeName>Edward</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chang</LastName>
                <ForeName>Kyong-Mi</ForeName>
                <Initials>KM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Park</LastName>
                <ForeName>Jang-June</ForeName>
                <Initials>JJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Belle</LastName>
                <ForeName>Steven H</ForeName>
                <Initials>SH</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wahed</LastName>
                <ForeName>Abdus</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kleiner</LastName>
                <ForeName>David</ForeName>
                <Initials>D</Initials>
            </Investigator>
        </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>04</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>05</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>6</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>6</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28581155</ArticleId>
            <ArticleId IdType="doi">10.1111/jvh.12732</ArticleId>
            <ArticleId IdType="pmc">PMC5638682</ArticleId>
            <ArticleId IdType="mid">NIHMS882171</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25010003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1150-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19785624</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Jul;46(1):254-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17596850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2001 Feb;107(4):449-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11181644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2009 Nov;137(5):1593-608.e1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19737565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2010 Nov;48(11):4161-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20810764</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2013 Jan;57(1):343-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23114756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2013 Feb;20(2):131-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23301548</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2010;15(3 Pt B):445-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20516564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2014 Aug;12(8):1363-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24342744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2015 Oct 17;386(10003):1546-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26231459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2014;19(2):201-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24275042</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2016 Jan;54(1):127-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26537448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2014 Sep;86(9):1473-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24861361</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2015 Feb;30(2):252-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25318660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2009 May 1;199(9):1275-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19301976</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">28183162</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>10</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2005-1212</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Mar</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Gut and liver</Title>
                <ISOAbbreviation>Gut Liver</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Management of Antiviral Resistance in Chronic Hepatitis B.</ArticleTitle>
            <Pagination>
                <MedlinePgn>189-195</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5009/gnl15562</ELocationID>
            <Abstract>
                <AbstractText>The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint to discontinue treatment. However, HBsAg seroclearance occurs very rarely with nucleos(t)ide analog (NUC) treatment, and long-term, almost indefinite, NUC treatment is required for the majority of patients. In patients with drug-resistant hepatitis B virus (HBV), a combination of tenofovir disoproxil fumarate (TDF) and entecavir (ETV), which is currently regarded as the strongest combination therapy against HBV, would be potentially safe to prevent the emergence of additional HBV resistance mutations. However, long-term tolerance data are lacking, and cost may be an issue for combination therapies. Several recent, well-designed, randomized controlled trials have shown that TDF monotherapy provides similar antiviral efficacy compared with the combination of TDF and ETV. Furthermore, no additional HBV resistance mutations emerged during TDF monotherapy for up to 96 weeks. Considering a comparable antiviral efficacy, extremely low risk of TDF-resistance, lower cost, and better safety potential, TDF monotherapy would be a reasonable choice for the treatment of drug-resistant patients with CHB.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lim</LastName>
                    <ForeName>Young-Suk</ForeName>
                    <Initials>YS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Gut Liver</MedlineTA>
            <NlmUniqueID>101316452</NlmUniqueID>
            <ISSNLinking>1976-2283</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D063065">Organophosphonates</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2T8Q726O95</RegistryNumber>
                <NameOfSubstance UI="D019259">Lamivudine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5968Y6H45M</RegistryNumber>
                <NameOfSubstance UI="C413685">entecavir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5Z93L87A1R</RegistryNumber>
                <NameOfSubstance UI="D006147">Guanine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>6GQP90I798</RegistryNumber>
                <NameOfSubstance UI="C053001">adefovir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>99YXE507IL</RegistryNumber>
                <NameOfSubstance UI="D000068698">Tenofovir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>JAC85A2161</RegistryNumber>
                <NameOfSubstance UI="D000225">Adenine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024921" MajorTopicYN="N">Drug Resistance, Multiple, Viral</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019259" MajorTopicYN="N">Lamivudine</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063065" MajorTopicYN="N">Organophosphonates</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000068698" MajorTopicYN="N">Tenofovir</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adefovir</Keyword>
            <Keyword MajorTopicYN="N">Entecavir</Keyword>
            <Keyword MajorTopicYN="N">Lamivudine</Keyword>
            <Keyword MajorTopicYN="N">Monotherapy</Keyword>
            <Keyword MajorTopicYN="N">Tenofovir</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>11</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>01</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28183162</ArticleId>
            <ArticleId IdType="pii">gnl15562</ArticleId>
            <ArticleId IdType="doi">10.5009/gnl15562</ArticleId>
            <ArticleId IdType="pmc">PMC5347642</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Hepatology. 2006 Jun;43(6):1385-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16729316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2014 Dec;12(12):2106-12.e1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24929235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2011 Feb;60(2):247-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21036792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2012 May;142(6):1369-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22537445</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2014 Apr;60(4):715-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24295873</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Mar;56(3):520-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22037226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2007 Mar;51(3):902-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17178796</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2004 Jan;126(1):91-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14699491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2007;12(8):1295-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18240869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2009 Feb;50(2):227-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19054588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2008 Dec;6(12 ):1315-41; quiz 1286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18845489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2014 Aug;63(8):1325-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24162593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2016 Jun;65(6):1042-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25800784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2013 Nov;58(5):1537-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23389810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Aug;125(2):292-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12891527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2016 Jan;63(1):261-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26566064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2007 Nov;133(5):1445-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17983801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2012 Jun;6(3):531-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26201469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2016 Jan;10 (1):1-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26563120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2010 Sep;53(3):449-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20646776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2006 Oct;55(10):1488-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16461777</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Liver Dis. 2007 Nov;11(4):869-92, ix</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17981233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 Sep;50(3):661-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19714720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2014 Jul;147(1):152-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24583062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2013 Jul;58(1):98-107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23213040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Oct 7;351(15):1521-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15470215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2014 Feb;59(2):434-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23939953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012;56 Suppl 1:S112-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22300461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2006 Oct;131(4):1253-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17030194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2014 May;12(5):885-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24107395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2005 Jun;41(6):1391-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15915463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2016 May;65(5):852-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25596179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2010 Jan;51(1):73-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19998272</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2010 Oct;139(4):1207-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20600025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Gastroenterol Hepatol. 2008 Aug;20(8):773-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18617782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2012 Mar;19(3):213-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22329376</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Mol Hepatol. 2012 Jun;18(2):109-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22893865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2010 Jul;53(1):118-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20471129</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2010 Feb;51(2):422-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20049753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Jul;57(1):167-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22436845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2014 Jul;147(1):143-151.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24704525</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 May;49(5):1503-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19280622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Sep;44(3):703-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16941700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2006 Jun;130(7):2039-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16762627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2005 Jul;42(1):121-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15962291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2007;12(3):355-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17591025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2003 Dec;39(6):1085-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14642631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dig Dis Sci. 2012 Nov;57(11):3011-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23010744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2013 Apr;58(4):676-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23219442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2014 Apr;146(4):980-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24368224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2006 Jan 4;295(1):65-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16391218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2007 Mar;46(3):531-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17239478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2005 Oct;129(4):1198-209</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16230074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2008 Sep;2(3):263-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19669255</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Feb;44(2):283-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16338024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Feb;45(2):307-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17256746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2006 Mar;130(3):678-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16530509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2004 Sep;48(9):3498-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15328117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2006 May;26(2):162-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16673294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 Oct;50(4):1064-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19637288</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2008 May;48(5):747-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18331765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2008 Dec 4;359(23):2442-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19052126</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27694733</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>02</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1972-2680</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Sep</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of infection in developing countries</Title>
                <ISOAbbreviation>J Infect Dev Ctries</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China.</ArticleTitle>
            <Pagination>
                <MedlinePgn>996-1002</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3855/jidc.8020</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Antiviral drug-resistance patterns of hepatitis B virus (HBV) mutants are complex and currently partly understood. The aim of this study was to monitor the genotypic resistance profile in patients with chronic hepatitis B (CHB) receiving nucleos(t)ide analogues (NAs) in Huzhou, eastern China.</AbstractText>
                <AbstractText Label="METHODOLOGY" NlmCategory="METHODS">Serum samples of 139 CHB patients undergoing NA treatment were obtained from Huzhou Central Hospital. The full-length HBV reverse transcriptase regions were amplified and sequenced. The NA resistance mutation positions, including rtL80, rtI169, rtV173, rtL180, rtA181, rtT184, rtA194, rtS202, rtM204, rtI233, rtN236, and rtM250 were analyzed.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Genotypic resistance mutations were detected in 41.72% (58/139) of patients with CHB. Drug resistance mutations were detected at positions rt80, rt173, rt180, rt181, rt194, rt202, rt204, rt236, and rt250, but were not observed at positions rt169, rt184, and rt233. The prevalence of mutations at rtM204 was 54.44% in 90 patients who were treated with lamivudine (LAM) or telbivudine (LDT). RtN236 mutations were detected in 7.14% (2/28) of the patients receiving adefovir (ADV) therapy. Additionally, rtA181 mutations were observed in 4 patients with LAM, ADV, and LDT-based therapy, but not in those patients treated with entecavir (ETV). Among patients who harbored rtM204 combination mutations, rtM204I and rtM204V were significantly associated with rtL80I/V and rtL180M, respectively.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The mutation patterns of NA-resistant HBV are complicated in CHB patients in the current clinical setting. Thus, it is necessary to persistently monitor the resistance mutations of HBV for optimizing antiviral therapy strategy and for preventing an outbreak of clinical resistance.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Qian</LastName>
                    <ForeName>Fuchu</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Huzhou Central Hospital, Huzhou, Zhejiang, China. qfc313009@126.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qin</LastName>
                    <ForeName>Jiqu</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Dongli</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Zhihong</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Hairong</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jin</LastName>
                    <ForeName>Fang</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Weihong</ForeName>
                    <Initials>W</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>09</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>J Infect Dev Ctries</MedlineTA>
            <NlmUniqueID>101305410</NlmUniqueID>
            <ISSNLinking>1972-2680</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009705">Nucleosides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009711">Nucleotides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009705" MajorTopicYN="N">Nucleosides</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009711" MajorTopicYN="N">Nucleotides</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044967" MajorTopicYN="N">Serum</DescriptorName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>12</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>02</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2016</Year>
                <Month>02</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>10</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>10</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>2</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27694733</ArticleId>
            <ArticleId IdType="doi">10.3855/jidc.8020</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27492206</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>06</Month>
            <Day>05</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1883-0498</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>62</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Jun</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Kobe journal of medical sciences</Title>
                <ISOAbbreviation>Kobe J Med Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Different Variants in Reverse Transcriptase Domain Determined by Ultra-deep Sequencing in Treatment-na√Øve and Treated Indonesian Patients Infected with Hepatitis B Virus.</ArticleTitle>
            <Pagination>
                <MedlinePgn>E1-8</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>A nucleos(t)ide analog (NA) is the common antiviral drug available for directly treating hepatitis B virus (HBV) infection. However, its application has led to the emergence of NA-resistant mutations mostly in a conserved region of the reverse transcriptase domain of HBV polymerase. Harboring NA-resistant mutations decreases drug effectiveness and increases the frequency of end-stage liver disease. The invention of next-generation sequencing that can generate thousands of sequences from viral complex mixtures provides opportunities to detect minor changes and early viral evolution under drug stress. The present study used ultra-deep sequencing to evaluate discrepant quasispecies in the reverse transcriptase domain of HBV including NA-resistant hotspots between seven treatment-na√Øve Indonesian patients infected with HBV and five at the early phase of treatment. The most common sub-genotype was HBV B3 (83.34%). The substitution rate of variants determined among amino acids with a ratio of ‚â• 1% changes was higher among the population in conserved regions (23.19% vs. 4.59%, P = 0.001) and in the inter-reverse transcriptase domain (23.95% vs. 2.94%, P = 0.002) in treatment na√Øve, than in treated patients. Nine hotspots of antiviral resistance were identified in both groups, and the mean frequency of changes in all patients was &lt; 1%. The known rtM204I mutation was the most frequent in both groups. The lower rate of variants in HBV quasispecies in patients undergoing treatment could be associated with virus elimination and the extinction of sensitive species by NA therapy. The present findings imply that HBV quasispecies dynamically change during treatment. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wasityastuti</LastName>
                    <ForeName>Widya</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Disease Pathology, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiology, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yano</LastName>
                    <ForeName>Yoshihiko</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Widasari</LastName>
                    <ForeName>Dewiyani Indah</ForeName>
                    <Initials>DI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomical Pathology, Dr. Sardjito Hospital, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamani</LastName>
                    <ForeName>Laura Navika</ForeName>
                    <Initials>LN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Disease Pathology, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ratnasari</LastName>
                    <ForeName>Neneng</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Subdivision of Gastroenterohepatology, Department of Internal Medicine, Dr. Sardjito Hospital, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heriyanto</LastName>
                    <ForeName>Didik Setyo</ForeName>
                    <Initials>DS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomical Pathology, Dr. Sardjito Hospital, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Okada</LastName>
                    <ForeName>Rina</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tanahashi</LastName>
                    <ForeName>Toshihito</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murakami</LastName>
                    <ForeName>Yoshiki</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Azuma</LastName>
                    <ForeName>Takeshi</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hayashi</LastName>
                    <ForeName>Yoshitake</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Disease Pathology, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>06</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>Kobe J Med Sci</MedlineTA>
            <NlmUniqueID>0413531</NlmUniqueID>
            <ISSNLinking>0023-2513</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015684">Gene Products, pol</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C066027">P protein, Hepatitis B virus</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015684" MajorTopicYN="N">Gene Products, pol</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007214" MajorTopicYN="N">Indonesia</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Drug resistance</Keyword>
            <Keyword MajorTopicYN="N">Hepatitis B virus</Keyword>
            <Keyword MajorTopicYN="N">Indonesia</Keyword>
            <Keyword MajorTopicYN="N">Reverse transcriptase domain</Keyword>
            <Keyword MajorTopicYN="N">Ultra-deep sequencing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>6</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27492206</ArticleId>
            <ArticleId IdType="pmc">PMC5433726</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Hepatology. 2006 Dec;44(6):1656-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17133475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2012 May;142(6):1303-1313.e1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22537437</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2006 Jul;13(7):427-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16792535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 Jan;49(1):50-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19065672</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2012 Jan;93(1):185-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22138714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Clin North Am. 2010 Sep;24(3):809-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20674805</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2012 Jun;6(3):531-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26201469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2014;57(6):384-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25382636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2012 Apr;12(4):341-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22326017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Virol. 2009;154(7):1047-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19499283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 Sep;50(3):661-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19714720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2001 Mar;33(3):751-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11230757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2012 Feb;84(2):207-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22170539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2013 Sep;2(9):e56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26038488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2014 Sep 7;20(33):11595-617</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25206267</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2013 Apr;20(4):234-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23490367</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2010 Dec;88(3):269-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20875460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2010 Apr;25(4):649-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20492319</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2001 Apr;82(Pt 4):883-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11257194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2015 Oct 14;21(38):10714-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26478663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Mar 30;10(3):e0117429</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25821965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Jul;57(1):167-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22436845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2012 Jun;86(11):6231-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22457522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 1997;4 Suppl 1:11-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9097273</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2010 Mar;85(3):512-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20034521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2015 Nov 24;5:17123</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26599443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011;6(9):e24907</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21966381</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2002 Jul 20;299(1):88-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12167344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Virol. 2008;153(6):1057-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18463783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2011 Nov;34(10):1145-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21978243</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2008 Jun;2(2):147-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19669299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Res. 2007 Aug;17(8):1195-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17600086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2007 Nov 1;23(21):2947-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17846036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2007 Jul;51(7):2285-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17438047</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">26309637</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>08</Month>
            <Day>28</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1940-5901</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2015</Year>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of clinical and experimental medicine</Title>
                <ISOAbbreviation>Int J Clin Exp Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Detection and analysis of resistance mutations of hepatitis B virus.</ArticleTitle>
            <Pagination>
                <MedlinePgn>9630-9</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the relationships of resistance mutations of hepatitis B virus (HBV) with replication and genotypes of HBV and to understand the common resistance mutations and mutation pattern.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The mutation patterns related to resistance to nucleoside drugs were analyzed, and the relationships of resistance mutations with HBV genotypes, Ct value, HBeAg, alanine aminotransferase (ALT), age and gender were evaluated.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Genotype B was found in 52 patients (73.2%) and genotype C in 19 patients (26.8%). In addition, 32 patients (45.07%) had resistance mutations at different loci, of which single base mutation accounted for 56.25% (18/32) and multi-base mutation for 43.75% (14/32). Of single base mutation, L180M, M204I, M204V and V173L had higher prevalence, and the incidence of L180M was closely related to the genotype of HBV. L180M, M204I and M204V were associated with the resistance to lamivudine and telbivudine; L180M, M204I, M204V and V173L were associated with the resistance to entecavir; A181T, N236T and N/H238T were related to the resistance to adefovir. Of multi-base mutations, L180M combined M204V had a high prevalence and were frequently found in patients with resistance to lamivudine and telbivudine. There was cross-resistance between lamivudine and telbivudine, between lamivudine and entecavir, and between entecavir and telbivudine. The Ct value of HBV DNA, HBeAg, ALT, age and gender were comparable among patients with different resistance mutations and HBV genotypes.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Detection of mutations of multiloci resistance genes is helpful for timely identification of HBV resistance and the clinical anti-virus therapy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Xiaohong</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, The First Hospital of Sun Yat-Sen University Guangzhou 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Fang</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, The First Hospital of Sun Yat-Sen University Guangzhou 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Bin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, The First Hospital of Sun Yat-Sen University Guangzhou 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Peisong</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, The First Hospital of Sun Yat-Sen University Guangzhou 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhong</LastName>
                    <ForeName>Liangying</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, The First Hospital of Sun Yat-Sen University Guangzhou 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2015</Year>
                <Month>06</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Int J Clin Exp Med</MedlineTA>
            <NlmUniqueID>101471010</NlmUniqueID>
            <ISSNLinking>1940-5901</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hepatitis B virus</Keyword>
            <Keyword MajorTopicYN="N">genotype</Keyword>
            <Keyword MajorTopicYN="N">nucleoside drugs</Keyword>
            <Keyword MajorTopicYN="N">resistance mutation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>03</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2015</Year>
                <Month>06</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2015</Year>
                <Month>8</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2015</Year>
                <Month>8</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>8</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">26309637</ArticleId>
            <ArticleId IdType="pmc">PMC4538069</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Hepatol. 2008 Jun;48(6):923-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18433925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Hepatol. 2014 May 27;6(5):284-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24868322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2005 Jan;12(1):67-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15655050</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2008 Jun;2(2):244-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19669311</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2007 Jun;39(2):87-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17451999</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2009 Nov;137(5):1593-608.e1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19737565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2012;17(2):291-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22301217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2012 Jan;67(1):39-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22001270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepat Mon. 2014 Jan 05;14(1):e13173</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24497877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2015 Mar;22(3):328-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25132017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Feb;44(2):422-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16364492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2005;10(5):625-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16152756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2004 Oct;9(5):679-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15535405</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2011 Mar;18(3):206-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20367795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin Med J (Engl). 2009 Jul 5;122(13):1585-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19719953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2005 Nov;12(6):609-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16255762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2015;20(2):141-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24992206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2005 Jun;41(6):1391-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15915463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2014 Mar;29(3):428-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24372662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2004 Oct;64(1):1-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15451174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2013 Jan;85(1):55-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23096938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Zhejiang Univ Sci B. 2005 Jul;6(7):664-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15973769</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2012 Feb;27(2):300-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21777282</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2011 Aug 08;8:393</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21824397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2010;15(8):1171-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21149924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin Med J (Engl). 2009 Jan 5;122(1):3-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19187608</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2004 Sep;48(9):3498-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15328117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2008 Jun;2(2):147-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19669299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2004 Jun;9(3):353-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15259898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Med. 2006;57:155-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16409142</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">26136470</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>05</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2015</Year>
            <Month>12</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1537-6613</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>213</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Jan</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of infectious diseases</Title>
                <ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).</ArticleTitle>
            <Pagination>
                <MedlinePgn>39-48</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiv363</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">European guidelines recommend treatment of chronic hepatitis B virus infection (CHB) with the nucleos(t)ide analogs (NAs) entecavir or tenofovir. However, many European CHB patients have been exposed to other NAs, which are associated with therapy failure and resistance. The CAPRE study was performed to gain insight in prevalence and characteristics of NA resistance in Europe.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">A survey was performed on genotypic resistance testing results acquired during routine monitoring of CHB patients with detectable serum hepatitis B virus DNA in European tertiary referral centers.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Data from 1568 patients were included. The majority (73.8%) were exposed to lamivudine monotherapy. Drug-resistant strains were detected in 52.7%. The most frequently encountered primary mutation was M204V/I (48.7%), followed by A181T/V (3.8%) and N236T (2.6%). In patients exposed to entecavir (n = 102), full resistance was present in 35.3%. Independent risk factors for resistance were age, viral load, and lamivudine exposure (P &lt; .001).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings support resistance testing in cases of apparent NA therapy failure. This survey highlights the impact of exposure to lamivudine and adefovir on development of drug resistance and cross-resistance. Continued use of these NAs needs to be reconsidered at a pan-European level.</AbstractText>
                <CopyrightInformation>¬© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hermans</LastName>
                    <ForeName>Lucas Etienne</ForeName>
                    <Initials>LE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Microbiology, University Medical Centre Utrecht Department of Virology, Erasmus Medical Centre, Rotterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Svicher</LastName>
                    <ForeName>Valentina</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pas</LastName>
                    <ForeName>Suzan Diepstraten</ForeName>
                    <Initials>SD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Erasmus Medical Centre, Rotterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salpini</LastName>
                    <ForeName>Romina</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alvarez</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Servicio de Microbiolog√≠a, Hospital San Cecilio, Instituto de Investigaci√≥n Biosanitaria ibs. GRANADA, Hospitales Universitarios de Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ben Ari</LastName>
                    <ForeName>Ziv</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Liver Disease Centre, Sheba Medical Centre, Ramat Gan, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boland</LastName>
                    <ForeName>Greet</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Microbiology, University Medical Centre Utrecht.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bruzzone</LastName>
                    <ForeName>Bianca</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hygiene Unit, IRCCS AOU San Martino - IST, Genoa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Coppola</LastName>
                    <ForeName>Nicola</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Malattie Infettive, Seconda Universit√† degli studi di Napoli, Naples, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seguin-Devaux</LastName>
                    <ForeName>Carole</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Retrovirology, CRP-Sant√©, Luxembourg.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dyda</LastName>
                    <ForeName>Tomasz</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Diagnostics Laboratory, Hospital of Infectious Diseases, Warsaw, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Garcia</LastName>
                    <ForeName>Federico</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Servicio de Microbiolog√≠a, Hospital San Cecilio, Instituto de Investigaci√≥n Biosanitaria ibs. GRANADA, Hospitales Universitarios de Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaiser</LastName>
                    <ForeName>Rolf</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Virology, University of Cologne, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>K√∂se</LastName>
                    <ForeName>Sukran</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic of Infectious Diseases and Clinical Microbiology, Izmir Tepecik Education and Research Hospital, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krarup</LastName>
                    <ForeName>Henrik</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lazarevic</LastName>
                    <ForeName>Ivana</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lunar</LastName>
                    <ForeName>Maja M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maylin</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service de Microbiologie, University Paris Diderot, H√¥pital Saint Louis, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Micheli</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lugi Sacco Hospital, Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mor</LastName>
                    <ForeName>Orna</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>National HIV Reference Laboratory, Central Virology Laboratory, Ministry of Health, Tel Hashomer, Ramat Gan, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paraschiv</LastName>
                    <ForeName>Simona</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Diagnostics Laboratory, National Institute for Infectious Diseases Matei Bals, Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paraskevis</LastName>
                    <ForeName>Dimitrios</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Retrovirus Reference Centre, Department of Hygiene, Epidemiology and Medical Statistics, Faculty of Medicine, National and Kapodistrian University of Athens, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Poljak</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Puchhammer-St√∂ckl</LastName>
                    <ForeName>Elisabeth</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department for Virology, Medical University of Vienna, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simon</LastName>
                    <ForeName>Fran√ßois</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service de Microbiologie, University Paris Diderot, H√¥pital Saint Louis, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stanojevic</LastName>
                    <ForeName>Maja</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stene-Johansen</LastName>
                    <ForeName>Kathrine</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tihic</LastName>
                    <ForeName>Nijaz</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Microbiology, Polyclinic for Laboratory Diagnostics, University Clinical Centre Tuzla, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trimoulet</LastName>
                    <ForeName>Pascale</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Laboratory, Centre Hospitalier R√©gional et Universit√© Victor Segalen, Bordeaux, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Verheyen</LastName>
                    <ForeName>Jens</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Virology, University-Hospital, University Duisburg-Essen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vince</LastName>
                    <ForeName>Adriana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Zagreb School of Medicine and University Hospital for Infectious Diseases &quot;Dr Fran Mihaljevic&quot;, Croatia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weis</LastName>
                    <ForeName>Nina</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Copenhagen University Hospital, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yalcinkaya</LastName>
                    <ForeName>T√ºlay</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Refik Saydam National Public Health Agency, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lepej</LastName>
                    <ForeName>Snjezana Zidovec</ForeName>
                    <Initials>SZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Zagreb School of Medicine and University Hospital for Infectious Diseases &quot;Dr Fran Mihaljevic&quot;, Croatia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perno</LastName>
                    <ForeName>Carlo</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boucher</LastName>
                    <ForeName>Charles A B</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Erasmus Medical Centre, Rotterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wensing</LastName>
                    <ForeName>Annemarie M J</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Microbiology, University Medical Centre Utrecht.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>HEPVIR Working Group of the European Society for Translational Antiviral Research</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2015</Year>
                <Month>07</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Infect Dis</MedlineTA>
            <NlmUniqueID>0413675</NlmUniqueID>
            <ISSNLinking>0022-1899</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">antiviral drug resistance</Keyword>
            <Keyword MajorTopicYN="N">genotypic resistance testing</Keyword>
            <Keyword MajorTopicYN="N">hepatitis B virus</Keyword>
            <Keyword MajorTopicYN="N">nucleos(t)ide analogs</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>03</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2015</Year>
                <Month>06</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2015</Year>
                <Month>7</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2015</Year>
                <Month>7</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>5</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">26136470</ArticleId>
            <ArticleId IdType="pii">jiv363</ArticleId>
            <ArticleId IdType="doi">10.1093/infdis/jiv363</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25493022</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>09</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2219-2840</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>45</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Dec</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>World journal of gastroenterology</Title>
                <ISOAbbreviation>World J. Gastroenterol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates.</ArticleTitle>
            <Pagination>
                <MedlinePgn>17100-6</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v20.i45.17100</ELocationID>
            <Abstract>
                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To investigate the loci of adefovir dipivoxil (ADV)-induced resistance in hepatitis B virus (HBV) isolates and optimize the management of ADV-treated patients.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Between June 2008 and August 2010, a cross-sectional control study was conducted comprising 79 patients with chronic HBV infection-related liver disease who had been administered ADV monotherapy. Patients underwent liver imaging. Serum DNA extracts were analyzed for HBV DNA levels, genotypes, and serology markers, and deep sequencing of the HBV P gene was performed.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">ADV-resistant patients were found either with a single mutated locus, or with coexisting mutated loci. The most prevalent mutations were rtA181T, rtV214A, and rtN236T. Twenty-six patients had more than two mutated loci. The mutants were distributed among the patients without any significant affinity for gender, age, end-stage of liver disease, complications of non-alcoholic fatty liver disease, or HBV DNA levels. Patients with the rtA181T mutant were primarily infected with genotype C and e-antigen negative HBV, while patients with the rtN236T mutant were primarily infected by genotype B HBV (œá(2) = 6.004, 7.159; P = 0.023, 0.007). The duration of treatment with ADV was shorter in the single mutant group compared with the multi-mutant group (t = 2.426, P = 0.018).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Drug-resistant HBV mutants are complex and diverse. Patients should receive the standard and first-line antiviral treatment, strictly comply with medication dosage, and avoid short-term withdrawal.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Su-Wen</ForeName>
                    <Initials>SW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yao</LastName>
                    <ForeName>Li-Peng</ForeName>
                    <Initials>LP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Ai-Rong</ForeName>
                    <Initials>AR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Yao-Ren</ForeName>
                    <Initials>YR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Shi-Xiang</ForeName>
                    <Initials>SX</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiong</LastName>
                    <ForeName>Tao</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Guo-Sheng</ForeName>
                    <Initials>GS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liang</LastName>
                    <ForeName>Xiao-Yue</ForeName>
                    <Initials>XY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>Shi-Xiong</ForeName>
                    <Initials>SX</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weng</LastName>
                    <ForeName>Peng-Jian</ForeName>
                    <Initials>PJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Su-Wen Jiang, Ai-Rong Hu, Yao-Ren Hu, Tao Xiong, Guo-Sheng Gao, Xiao-Yue Liang, Shi-Xiong Ding, Peng-Jian Weng, Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo 315010, Zhejiang Province, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World J Gastroenterol</MedlineTA>
            <NlmUniqueID>100883448</NlmUniqueID>
            <ISSNLinking>1007-9327</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D063065">Organophosphonates</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>JAC85A2161</RegistryNumber>
                <NameOfSubstance UI="D000225">Adenine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>U6Q8Z01514</RegistryNumber>
                <NameOfSubstance UI="C106812">adefovir dipivoxil</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003952" MajorTopicYN="N">Diagnostic Imaging</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063065" MajorTopicYN="N">Organophosphonates</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adefovir dipivoxil</Keyword>
            <Keyword MajorTopicYN="N">Drug-resistant mutant</Keyword>
            <Keyword MajorTopicYN="N">Gene sequencing</Keyword>
            <Keyword MajorTopicYN="N">Hepatitis B virus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>05</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>9</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25493022</ArticleId>
            <ArticleId IdType="doi">10.3748/wjg.v20.i45.17100</ArticleId>
            <ArticleId IdType="pmc">PMC4258578</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Antivir Ther. 2012;17(5):793-803</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22668794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Apr;32(4):405-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21569677</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2007 Nov 15;196(10):1483-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18008227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Jul;46(1):254-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17596850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2013 Mar;37(5):517-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23305043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2009 Nov;137(5):1593-608.e1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19737565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2012 Nov;96(2):100-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22960601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Feb;44(2):422-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16364492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2012 Jun;6(3):531-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26201469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2008 Jul;48(1):88-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18537180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2007 Oct;47(4):492-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17692425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2004 Oct;9(5):679-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15535405</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dig Dis. 2011 Feb;12(1):38-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21276207</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2007;12 Suppl 3:H15-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18284179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 Sep;50(3):661-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19714720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(4):e35052</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22523569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012;56 Suppl 1:S112-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22300461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2005 Nov;12(6):609-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16255762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2008 Dec;6(12):1315-41; quiz 1286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18845489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin Med J (Engl). 2013 Jul;126(13):2430-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23823813</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genet Mol Res. 2012;11(1):53-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22290465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2003;46(6):329-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14688448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2011;11:398</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21933446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Jul;57(1):167-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22436845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2007;12(3):355-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17591025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dig Dis Sci. 2012 Jan;57(1):221-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21743991</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2012 Jun;142(7):1592-609</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22656328</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Gan Zang Bing Za Zhi. 2009 Dec;17(12):952-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20038344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Yi Xue Za Zhi. 2012 Jul 17;92(27):1878-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23134956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Case Rep. 2009;2009:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21686872</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2009 Sep;81(9):1551-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19626620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2005 Jul;12(4):398-404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15985011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Feb;44(2):283-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16338024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2010;15(8):1171-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21149924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2010 Mar;17 Suppl 1:10-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20586929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2010 Mar;17 Suppl 1:66-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20586936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2008 Jun;2(2):147-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19669299</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">24835494</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>08</Month>
            <Day>31</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e97759</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0097759</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hepatitis B virus (HBV) infection is a major global health burden with distinct geographic public health significance. Oman is a country with intermediate HBV carrier prevalence; however, little is known about the incidence of HBV variants in circulation. We investigated the HBV genotype distribution, the occurrence of antiviral resistance, and HBV surface antigen (HBsAg) escape mutations in HBsAg-positive patients in Oman.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Serum samples were collected from 179 chronically HBV-infected patients enrolled in various gastroenterology clinics in Oman. HBV genotypes were determined by sequencing and phylogenetic analysis. Mutations in the HBV polymerase and the HBsAg gene were characterized by mutational analysis.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">HBV genotypes D (130/170; 76.47%) and A (32/170; 18.28%) are predominant in Oman. The HBV genotypes C and E were less frequent (each 1.18%), while the HBV genotypes B, G, F, and H were not detected. Four patients revealed HBV genotype mixtures (HBV-A/D and D/C). The analyses of vaccine escape mutations yield that 148/170 (87.06%) HBV sequences were wild type. 22/170 (12.94%) HBV sequences showed mutations in the &quot;a&quot; determinant of the HBsAg domain. Two patients showed the described HBV vaccine escape mutation sP120T. 8/146 (5.48%) HBV isolates harbored mutations in the HBV polymerase known to confer resistance against antiviral therapy. Especially the lamivudine resistance mutations rtL180M/rtM204V and rtM204I were detected.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study shows the distribution of HBV genotypes, therapy resistance, and vaccine escape mutations in HBV-infected patients in Oman. Our findings will have a major impact on therapy management and diagnostics of chronic HBV infections in Oman to control HBV infection in this intermediate HBV-endemic country.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Al Baqlani</LastName>
                    <ForeName>Said Ali</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Public Health Laboratory - Ministry of Health, Muscat, Oman.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sy</LastName>
                    <ForeName>Bui Tien</ForeName>
                    <Initials>BT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany; Vietnam Military Medical University, Ha Dong, Ha Noi, Viet Nam; Institute of Tropical Medicine, University of T√ºbingen, T√ºbingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ratsch</LastName>
                    <ForeName>Boris A</ForeName>
                    <Initials>BA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al Naamani</LastName>
                    <ForeName>Khalid</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Armed Forces Hospital - Ministry of Defense, Muscat, Oman.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al Awaidy</LastName>
                    <ForeName>Salah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Office of the Undersecretary for Health Affairs - Ministry of Health, Muscat, Oman.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Busaidy</LastName>
                    <ForeName>Suleiman Al</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Public Health Laboratory - Ministry of Health, Muscat, Oman.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pauli</LastName>
                    <ForeName>Georg</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bock</LastName>
                    <ForeName>C-Thomas</ForeName>
                    <Initials>CT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>05</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017325">Hepatitis B Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018894">Reverse Transcriptase Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2T8Q726O95</RegistryNumber>
                <NameOfSubstance UI="D019259">Lamivudine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017325" MajorTopicYN="N">Hepatitis B Vaccines</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019259" MajorTopicYN="N">Lamivudine</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009850" MajorTopicYN="N" Type="Geographic">Oman</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018894" MajorTopicYN="N">Reverse Transcriptase Inhibitors</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>01</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>04</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>9</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24835494</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0097759</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-04114</ArticleId>
            <ArticleId IdType="pmc">PMC4023993</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2000 Jan;81(Pt 1):67-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10640543</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1998 Jan;27(1):213-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9425940</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Trop Med Hyg. 2013 Oct;89(4):811-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23958910</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2012 Feb;84(2):198-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22170538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2002 May;35(5):1274-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11981779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2009 Nov 5;27(47):6550-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19729084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 1995;13(8):699-702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7483783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 1998 Mar;36(3):648-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9508289</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2004;47(6):289-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15564741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2005 Oct 15-21;366(9494):1337-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16226597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Evol. 2011 Oct;28(10):2731-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21546353</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Gastroenterol. 2013 May;29(3):250-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23519135</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2011 Dec;10(12):1709-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22085174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2005 Apr 7;11(13):1976-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15800989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2005 Jul;76(3):318-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15902699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2006 Mar;78(3):353-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16419125</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2006 Mar;52(3):202-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16271396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(6):e39027</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22720022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2009 Sep;50(3):661-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19714720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2005 Feb;32(2):102-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15653412</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2013 Feb;58(2):212-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23022497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2002 Feb;122(2):264-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11832441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2010;15(3 Pt B):451-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20516565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2009 Jun;3(2):334-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19669359</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Gastroenterol. 2009 May;25(3):180-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19387254</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2002 Jun;17(6):643-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12100608</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Jun;43(6):1375-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16729315</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2010 Oct 1;26(19):2462-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20798170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1997 Aug;26(2):495-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9252165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Jpn J Infect Dis. 2012;65(6):476-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23183198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2010;15(3 Pt B):445-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20516564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2013 Jul;20(7):494-501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23730843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Recent Results Cancer Res. 2014;193:75-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24008294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2002 Aug;25(2):97-106</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12367644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2002 Sep 15;186(6):752-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12198608</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Princ Pract. 2006;15(5):368-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16888395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2013 Dec;59(6):1153-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23872601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2012 Jul;57(1):167-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22436845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1995 Jun 3;345(8962):1406-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7539089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2010 Sep;17(9):601-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20529201</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2003 Oct;60(2):75-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14638401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Carcinogenesis. 2008 Sep;29(9):1685-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18192693</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 1997;4 Suppl 1:11-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9097273</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2003 Feb;23(1):5-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12616447</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):911-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19577871</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Jul;125(1):107-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12851876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Iran Med. 2012 Jul;15(7):446-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22724883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1999 Nov;30(5):1312-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10534356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2004 May;73(1):23-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15042643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2008 Oct;80(10):1707-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18712830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1997 Dec;26(6):1658-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9398013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2004 Oct;40(4):790-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15382157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2003 Aug;70(4):529-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12794714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2002 Dec;123(6):1848-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12454842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2001 Aug;34(2):432-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11481631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 1999 Jul;6(4):299-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10607244</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">24790911</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>04</Month>
            <Day>06</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2234-3814</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>34</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of laboratory medicine</Title>
                <ISOAbbreviation>Ann Lab Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Analysis of reverse transcriptase gene mutations in the hepatitis B virus at a university hospital in Korea.</ArticleTitle>
            <Pagination>
                <MedlinePgn>230-4</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3343/alm.2014.34.3.230</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Most mutations in the reverse transcriptase (RT) gene of the hepatitis B virus (HBV) are related to resistance to antiviral agents. Cross-sectional studies on the mutations of this gene are rare. Thus, we analyzed the mutation patterns of RT genes and their biochemical parameters.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">From 2009 to 2012, 301 blood specimens from patients with chronic hepatitis B at Daegu Catholic University Medical Center were retrospectively analyzed for the RT gene sequence of HBV, ALT, hepatitis B e antigen (HBeAg), and HBV DNA. The mutation patterns of the RT gene were compared with the biochemical parameters.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 301 patients, 100 (33.2%) had no RT gene mutations. The remaining showed the following mutation patterns: rtM204I/V (50.2%), rtL180M (39.2%), and rtA181T/V (19.6%). Combined mutations were found in 146 cases (48.5%). Of these, the combination of amino acid changes at rt180+rt204 (49.3%) was most frequently detected, followed by rt181+rt236 (11.0%) and rt173+rt180+rt204 (9.6%). In the mutated group, HBV DNA and HBeAg positive rates were significantly higher (P&lt;0.05 for both). Phenotypic analysis showed that lamivudine resistance was most frequently detected (34.6%), followed by adefovir resistance (15.6%). Multidrug resistance was detected in 48 cases (15.9%). The adefovir-resistant group had a higher proportion of cases with HBV loads greater than 2,000 IU/mL.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found correlations between the mutation status of the RT domain and biochemical parameters such as HBV DNA and HBeAg positive rate. The presence of RT gene mutations could therefore be utilized to predict clinical status.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>A-Jin</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, College of Medicine, Catholic University of Daegu, Daegu, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Chang Hyeong</ForeName>
                    <Initials>CH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, College of Medicine, Catholic University of Daegu, Daegu, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeon</LastName>
                    <ForeName>Chang-Ho</ForeName>
                    <Initials>CH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, College of Medicine, Catholic University of Daegu, Daegu, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>04</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Ann Lab Med</MedlineTA>
            <NlmUniqueID>101571172</NlmUniqueID>
            <ISSNLinking>2234-3806</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006513">Hepatitis B e Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D063065">Organophosphonates</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2T8Q726O95</RegistryNumber>
                <NameOfSubstance UI="D019259">Lamivudine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>6GQP90I798</RegistryNumber>
                <NameOfSubstance UI="C053001">adefovir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>JAC85A2161</RegistryNumber>
                <NameOfSubstance UI="D000225">Adenine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024921" MajorTopicYN="N">Drug Resistance, Multiple, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006513" MajorTopicYN="N">Hepatitis B e Antigens</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019259" MajorTopicYN="N">Lamivudine</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063065" MajorTopicYN="N">Organophosphonates</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Alanine aminotransferase</Keyword>
            <Keyword MajorTopicYN="N">Hepatitis B e antigen</Keyword>
            <Keyword MajorTopicYN="N">Hepatitis B virus</Keyword>
            <Keyword MajorTopicYN="N">Mutation</Keyword>
            <Keyword MajorTopicYN="N">Reverse transcriptase</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>07</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>02</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>4</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24790911</ArticleId>
            <ArticleId IdType="doi">10.3343/alm.2014.34.3.230</ArticleId>
            <ArticleId IdType="pmc">PMC3999322</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Braz J Infect Dis. 2012 May-Jun;16(3):250-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22729192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Korean J Hepatol. 2008 Dec;14(4):446-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19119240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Ther. 2009 Feb;31(2):360-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19302908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2005 Feb 14;11(6):867-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15682483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2007 Nov;79(11):1664-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17854034</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2001 Feb;107(4):449-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11181644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Mar;44(3):593-606</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16455151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Hepatol. 2012 Mar 27;4(3):74-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22489259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2006;78 Suppl 1:S52-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16622878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Infect Dis. 2012 Jan;44(1):44-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21851334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2003 Jun;37(6):1309-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12774009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2007;12 Suppl 3:H15-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18284179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Folia Med (Plovdiv). 1998;40(4):34-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10371797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 1999 May;6(3):183-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10607230</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infection. 2008 Oct;36(5):472-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17962902</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Mol Hepatol. 2012 Jun;18(2):109-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22893865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2004 Oct;99(10):2032-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15447768</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Korean J Hepatol. 2008 Dec;14(4):503-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19119245</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">24630522</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>02</Month>
            <Day>06</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>04</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0070</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>79</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Diagnostic microbiology and infectious disease</Title>
                <ISOAbbreviation>Diagn. Microbiol. Infect. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method.</ArticleTitle>
            <Pagination>
                <MedlinePgn>25-30</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.diagmicrobio.2014.01.005</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0732-8893(14)00016-9</ELocationID>
            <Abstract>
                <AbstractText>The potential antiviral resistance mutations within hepatitis B virus (HBV) reverse transcriptase (RT) region for nucleos(t)ide analogues (NA) are not well known. Especially, the effect of pre-existing antiviral drug resistance mutations in untreated patients in comparison to the resistance developed after treatment is not still clear. Sixteen naive chronic hepatitis B patients were studied. None of the patients had received NA treatment prior to the serum samples being collected. Forty-two potential NA resistance (NAr) mutation sites were screened by ultra-deep pyrosequencing (UDPS). After therapy, mutations conferring treatment resistance were detected by LiPA. Serum samples taken before treatment showed no classic primary or compensatory/secondary drug resistance mutations. However, NAr mutations found in 6 isolates (37.5%) involved 7 positions including rtL91I, rtT128I, rtQ215P, rtF221Y, rtN238D, rtC256S, and rtI266G. Substitutions at 3 NAr mutation sites (rtT128I, rtN238D, and rtC256S) were detected in 3 unresponsive patients developing drug resistance after NA treatment. One patient with rtI266G mutation also developed drug resistance after lamivudine (LAM) therapy. However, the relationship between rtI266G mutation and NA drug resistance was not previously reported. These results suggest that association of potential mutations besides the primary and secondary/compensatory resistance mutations should be investigated. Investigation of NAr mutations before treatment may be important for the success of the treatment. </AbstractText>
                <CopyrightInformation>Copyright ¬© 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ciftci</LastName>
                    <ForeName>Sevgi</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Faculty of Dentistry, Istanbul University, 34390 Istanbul, Turkey. Electronic address: sevgiciftci@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keskin</LastName>
                    <ForeName>Fahriye</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Faculty of Dentistry, Istanbul University, 34390 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cakiris</LastName>
                    <ForeName>Aris</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Experimental Medical Research, Istanbul University, 34393 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Akyuz</LastName>
                    <ForeName>Filiz</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterohepatology, Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pinarbasi</LastName>
                    <ForeName>Binnur</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterohepatology, Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abaci</LastName>
                    <ForeName>Neslihan</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Experimental Medical Research, Istanbul University, 34393 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dincer</LastName>
                    <ForeName>Erdinc</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Experimental Medical Research, Istanbul University, 34393 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Badur</LastName>
                    <ForeName>Selim</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Microbiology and Clinical Microbiology, Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaymakoglu</LastName>
                    <ForeName>Sabahattin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterohepatology, Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ustek</LastName>
                    <ForeName>Duran</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Experimental Medical Research, Istanbul University, 34393 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>01</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Diagn Microbiol Infect Dis</MedlineTA>
            <NlmUniqueID>8305899</NlmUniqueID>
            <ISSNLinking>0732-8893</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005814" MajorTopicYN="N">Genes, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058889" MajorTopicYN="N">Molecular Typing</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">HBV-RT domain</Keyword>
            <Keyword MajorTopicYN="N">Potential mutations</Keyword>
            <Keyword MajorTopicYN="N">UDPS</Keyword>
            <Keyword MajorTopicYN="N">Untreated chronic patients</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>08</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>01</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>01</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24630522</ArticleId>
            <ArticleId IdType="pii">S0732-8893(14)00016-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.diagmicrobio.2014.01.005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">24016777</PMID>
        <DateCompleted>
            <Year>2014</Year>
            <Month>04</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2016</Year>
            <Month>05</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-6265</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>3</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Current opinion in virology</Title>
                <ISOAbbreviation>Curr Opin Virol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hepatitis B antivirals and resistance.</ArticleTitle>
            <Pagination>
                <MedlinePgn>495-500</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.coviro.2013.08.006</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S1879-6257(13)00142-9</ELocationID>
            <Abstract>
                <AbstractText>Antiviral therapy for chronic hepatitis B (CHB) has improved the outcome of patients. However, due to the multiple selection pressures of different nucleos(t)ide analogue, drug resistant HBV variants have emerged. Because of the arrangement of overlapping reading frames in HBV genome, these variants not only have clinical implications such as drug resistance, but also the potential to pose public health issues via vaccine escape. Whilst emergence of these variants cannot be prevented, careful selection and institution of the appropriate rescue anti viral therapy based on high genetic barrier and high potency should minimize this outcome. </AbstractText>
                <CopyrightInformation>Copyright ¬© 2013 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Devi</LastName>
                    <ForeName>Uma</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health, Victoria, Australia; Research &amp; Molecular Development, Victorian Infectious Diseases Reference Laboratory, 10 Wreckyn St, North Melbourne, VIC 3051, Australia. Electronic address: Uma.Devi@mh.org.au.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Locarnini</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>09</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Curr Opin Virol</MedlineTA>
            <NlmUniqueID>101560941</NlmUniqueID>
            <ISSNLinking>1879-6257</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>06</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2013</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>08</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>9</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>9</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24016777</ArticleId>
            <ArticleId IdType="pii">S1879-6257(13)00142-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.coviro.2013.08.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23458519</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>08</Month>
            <Day>05</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1365-2893</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20 Suppl 1</Volume>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of viral hepatitis</Title>
                <ISOAbbreviation>J. Viral Hepat.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Telbivudine treatment in chronic hepatitis B: experience from China.</ArticleTitle>
            <Pagination>
                <MedlinePgn>3-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/jvh.12058</ELocationID>
            <Abstract>
                <AbstractText>Telbivudine, one of the oral anti-hepatitis B virus (HBV) nucleoside analogues, has been used for more than 5 years to treat HBeAg-positive and -negative chronic hepatitis B (CHB) patients. This includes not only global Phase II and III trials, but also Chinese Phase III trials and several real-world clinical practice studies from China. The present review will first focus on 1-, 2- and 3-year data of telbivudine therapy on HBV DNA suppression, alanine aminotransferase (ALT) normalization, hepatitis B e antigen (HBeAg) seroconversion, viral resistance and safety in HBeAg-positive and -negative CHB patients. Second, telbivudine treatment predictors, including HBV DNA undetectability, ALT level and other immune-related markers at 12 and 24 weeks will be summarized to optimize therapy. Besides several retrospective studies, the Chinese EFFORT prospective study adapted from telbivudine virological response at 24 weeks has shown very promising results. Finally, the Chinese experience of using telbivudine in the second and third trimesters of pregnancy to prevent perinatal transmission of HBV infection will be touched on citing the latest studies.</AbstractText>
                <CopyrightInformation>¬© 2012 Blackwell Publishing Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>You</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jia</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Viral Hepat</MedlineTA>
            <NlmUniqueID>9435672</NlmUniqueID>
            <ISSNLinking>1352-0504</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006513">Hepatitis B e Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2OC4HKD3SF</RegistryNumber>
                <NameOfSubstance UI="D000077712">Telbivudine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>VC2W18DGKR</RegistryNumber>
                <NameOfSubstance UI="D013936">Thymidine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006513" MajorTopicYN="N">Hepatitis B e Antigens</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018445" MajorTopicYN="N">Infectious Disease Transmission, Vertical</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000077712" MajorTopicYN="N">Telbivudine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013936" MajorTopicYN="N">Thymidine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>05</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2012</Year>
                <Month>12</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>3</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>3</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>8</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23458519</ArticleId>
            <ArticleId IdType="doi">10.1111/jvh.12058</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23409946</PMID>
        <DateCompleted>
            <Year>2014</Year>
            <Month>01</Month>
            <Day>22</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1743-422X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Feb</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Virology journal</Title>
                <ISOAbbreviation>Virol. J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization of antiviral resistance mutations among the Eastern Indian Hepatitis B virus infected population.</ArticleTitle>
            <Pagination>
                <MedlinePgn>56</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/1743-422X-10-56</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antiviral therapy using nucleos(t)ide analogues (NAs) is an effective control measure of chronic hepatitis B virus (HBV) infection; however they need long term treatment. Presence of drug-resistance mutations may get in the way of the efficacy of antiviral therapy. Our study was aimed at defining the prevalence of HBV drug-resistance in HBVrt region in a population of 147 HBsAg positive patients.</AbstractText>
                <AbstractText Label="FINDINGS" NlmCategory="RESULTS">HBV/D has shown multiple types of HBVrt mutations both among treatment na√Øve (65.0%, 13 of 20 HBV/D) and treated patients (56.2%, 9 of 16 HBV/D). In additional, several mutations, with a suggested role in drug resistance, were detected among the treatment na√Øve as well as the treated patients. The mutations reported to be involved in reduction of drug effectiveness, was common among non-responders to therapy as well as among the na√Øve patients. Notably, classical antiviral resistance mutations (rtL80I/V-rtI169T-rtV173L-rtL180M-rtA181T/V/S-rtT184A/S/G/C-rtA194T-rtS202C /G/I -rtM204V/I-rtN236T-rtM250V) were not detected.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The prevalence of putative NAr mutations among non responders to therapy suggests that they might have role in reduced efficacy of currently available antivirals and requires further investigations.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Panigrahi</LastName>
                    <ForeName>Rajesh</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICMR Virus Unit, Kolkata, ID &amp; BG Hospital Campus, Kolkata, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Biswas</LastName>
                    <ForeName>Avik</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>De</LastName>
                    <ForeName>Binay Krishna</ForeName>
                    <Initials>BK</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chakrabarti</LastName>
                    <ForeName>Sekhar</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chakravarty</LastName>
                    <ForeName>Runu</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>GENBANK</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>JQ316695</AccessionNumber>
                        <AccessionNumber>JQ316696</AccessionNumber>
                        <AccessionNumber>JQ316697</AccessionNumber>
                        <AccessionNumber>JQ316698</AccessionNumber>
                        <AccessionNumber>JQ316699</AccessionNumber>
                        <AccessionNumber>JQ316700</AccessionNumber>
                        <AccessionNumber>JQ316701</AccessionNumber>
                        <AccessionNumber>JQ316702</AccessionNumber>
                        <AccessionNumber>JQ316703</AccessionNumber>
                        <AccessionNumber>JQ316704</AccessionNumber>
                        <AccessionNumber>JQ316705</AccessionNumber>
                        <AccessionNumber>JQ316706</AccessionNumber>
                        <AccessionNumber>JQ316707</AccessionNumber>
                        <AccessionNumber>JQ316708</AccessionNumber>
                        <AccessionNumber>JQ316709</AccessionNumber>
                        <AccessionNumber>JQ316710</AccessionNumber>
                        <AccessionNumber>JQ316711</AccessionNumber>
                        <AccessionNumber>JQ316712</AccessionNumber>
                        <AccessionNumber>JQ316713</AccessionNumber>
                        <AccessionNumber>JQ316714</AccessionNumber>
                        <AccessionNumber>JQ316715</AccessionNumber>
                        <AccessionNumber>JQ316716</AccessionNumber>
                        <AccessionNumber>JQ316717</AccessionNumber>
                        <AccessionNumber>JQ316718</AccessionNumber>
                        <AccessionNumber>JQ316719</AccessionNumber>
                        <AccessionNumber>JQ316720</AccessionNumber>
                        <AccessionNumber>JQ316721</AccessionNumber>
                        <AccessionNumber>JQ316722</AccessionNumber>
                        <AccessionNumber>JQ316723</AccessionNumber>
                        <AccessionNumber>JQ316724</AccessionNumber>
                        <AccessionNumber>JQ316725</AccessionNumber>
                        <AccessionNumber>JQ316726</AccessionNumber>
                        <AccessionNumber>JQ316727</AccessionNumber>
                        <AccessionNumber>JQ316728</AccessionNumber>
                        <AccessionNumber>JQ316729</AccessionNumber>
                        <AccessionNumber>JQ316730</AccessionNumber>
                        <AccessionNumber>JQ316731</AccessionNumber>
                        <AccessionNumber>JQ316732</AccessionNumber>
                        <AccessionNumber>JQ316733</AccessionNumber>
                        <AccessionNumber>JQ316734</AccessionNumber>
                        <AccessionNumber>JQ316735</AccessionNumber>
                        <AccessionNumber>JQ316736</AccessionNumber>
                        <AccessionNumber>JQ316737</AccessionNumber>
                        <AccessionNumber>JQ316738</AccessionNumber>
                        <AccessionNumber>JQ316739</AccessionNumber>
                        <AccessionNumber>JQ316740</AccessionNumber>
                        <AccessionNumber>JQ316741</AccessionNumber>
                        <AccessionNumber>JQ316742</AccessionNumber>
                        <AccessionNumber>JQ316743</AccessionNumber>
                        <AccessionNumber>JQ316744</AccessionNumber>
                        <AccessionNumber>JQ316745</AccessionNumber>
                        <AccessionNumber>JQ316746</AccessionNumber>
                        <AccessionNumber>JQ316747</AccessionNumber>
                        <AccessionNumber>JQ316748</AccessionNumber>
                        <AccessionNumber>JQ316749</AccessionNumber>
                        <AccessionNumber>JQ316750</AccessionNumber>
                        <AccessionNumber>JQ316751</AccessionNumber>
                        <AccessionNumber>JQ316752</AccessionNumber>
                        <AccessionNumber>JQ316753</AccessionNumber>
                        <AccessionNumber>JQ316754</AccessionNumber>
                        <AccessionNumber>JQ316755</AccessionNumber>
                        <AccessionNumber>JQ316756</AccessionNumber>
                        <AccessionNumber>JQ316757</AccessionNumber>
                        <AccessionNumber>JQ316758</AccessionNumber>
                        <AccessionNumber>JQ316759</AccessionNumber>
                        <AccessionNumber>JQ316760</AccessionNumber>
                        <AccessionNumber>JQ316761</AccessionNumber>
                        <AccessionNumber>JQ316762</AccessionNumber>
                        <AccessionNumber>JQ316763</AccessionNumber>
                        <AccessionNumber>JQ316764</AccessionNumber>
                        <AccessionNumber>JQ316765</AccessionNumber>
                        <AccessionNumber>JQ316766</AccessionNumber>
                        <AccessionNumber>JQ316767</AccessionNumber>
                        <AccessionNumber>JQ316768</AccessionNumber>
                        <AccessionNumber>JQ316769</AccessionNumber>
                        <AccessionNumber>JQ316770</AccessionNumber>
                        <AccessionNumber>JQ316771</AccessionNumber>
                        <AccessionNumber>JQ316772</AccessionNumber>
                        <AccessionNumber>JQ316773</AccessionNumber>
                        <AccessionNumber>JQ316774</AccessionNumber>
                        <AccessionNumber>JQ316775</AccessionNumber>
                        <AccessionNumber>JQ316776</AccessionNumber>
                        <AccessionNumber>JQ316777</AccessionNumber>
                        <AccessionNumber>JQ316778</AccessionNumber>
                        <AccessionNumber>JQ316779</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>02</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Virol J</MedlineTA>
            <NlmUniqueID>101231645</NlmUniqueID>
            <ISSNLinking>1743-422X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>05</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>01</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>2</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>2</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23409946</ArticleId>
            <ArticleId IdType="pii">1743-422X-10-56</ArticleId>
            <ArticleId IdType="doi">10.1186/1743-422X-10-56</ArticleId>
            <ArticleId IdType="pmc">PMC3621210</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Hepatology. 2001 Mar;33(3):751-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11230757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2012;55(1):36-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21311172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Feb;44(2):422-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16364492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2006;78 Suppl 1:S52-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16622878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2006 May;26(2):162-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16673294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Jul;46(1):254-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17596850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2007 Jul;51(7):2285-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17438047</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2007 Oct;47(4):492-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17692425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2009 Feb;83(4):1718-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19073746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2009 Mar;50(3):461-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19041149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2009 Feb 14;15(6):753-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19222103</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2009 Aug;47(8):2544-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19553583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2009 Oct;83(19):9983-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19420079</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Viral Hepat. 2009 Oct;16(10):749-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19457142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2010 Mar;85(3):512-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20034521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2011 Feb;83(2):253-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21181919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2011 Nov;92(2):382-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21920388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 2004;47(6):289-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15564741</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">21920388</PMID>
        <DateCompleted>
            <Year>2012</Year>
            <Month>02</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2011</Year>
            <Month>10</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-9096</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>92</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Antiviral research</Title>
                <ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, na√Øve to antiviral drugs.</ArticleTitle>
            <Pagination>
                <MedlinePgn>382-5</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2011.08.013</ELocationID>
            <Abstract>
                <AbstractText>Presence of drug-resistance mutations in drug-na√Øve hepatitis B virus (HBV) infected patients can seriously compromise response to antiviral treatment. Therefore, our study was aimed at defining the prevalence of HBV drug-resistance in a population of 140 patients, all infected with HBV-D-genotype (the most common HBV-genotype in Eastern Europe, Mediterranean countries and Middle East) and na√Øve to antiviral therapy. HBV reverse-transcriptase (RT) region was sequenced and analyzed for 20 mutations, confirmed by in vitro studies as associated with resistance to nucleos(t)ide HBV-RT inhibitors (rtL80I/V-rtI169T-rtV173L-rtL180M-rtA181T/V/S-rtT184A/S/G/C-rtA194T-rtS202C/G/I-rtM204V/I-rtN236T-rtM250V). Amino acid changes at other six RT positions, potentially associated with resistance, were also analyzed (rtV84M-rtV191I-rtV207L-rtV214A-rtQ215S-rtI233V). Overall, only 2/140 (1.4%) patients carried primary drug-resistance mutations [rtA181V (0.7%), and rtA194T (0.7%)], while 3/140 (2.1%) patients harbored the secondary mutations rtV173L (1.4%) and rtL180M (0.7%). Additionally, five polymorphic mutations, with a suggested role in drug resistance, were detected [rtQ215S (12.8%), rtI233V (4.3%), rtV214A (3.6%), rtV191I (0.7%), rtV207L (0.7%)]. Notably, no YMDD mutations, namely rtM204V/I, were found. Taken together, the rate of important drug resistance mutations in na√Øve HBV D-genotype infected patients is today very low, and suggests the potential full efficacy of new-generation antiviral drugs used in first line therapy. Whether such low rate can be extrapolated to non HBV-D subtypes, requires a detailed investigation to be performed in a different cohort of patients.</AbstractText>
                <CopyrightInformation>Copyright ¬© 2011 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Salpini</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Medicine and Biochemical Science, University of Tor Vergata, Via Montpellier 1, 00100 Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Svicher</LastName>
                    <ForeName>V</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cento</LastName>
                    <ForeName>V</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gori</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bertoli</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scopelliti</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Micheli</LastName>
                    <ForeName>V</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cappiello</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Span√≤</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rizzardini</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>De Sanctis</LastName>
                    <ForeName>G M</ForeName>
                    <Initials>GM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sarrecchia</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Angelico</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perno</LastName>
                    <ForeName>C F</ForeName>
                    <Initials>CF</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>GENBANK</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>JN225963</AccessionNumber>
                        <AccessionNumber>JN225964</AccessionNumber>
                        <AccessionNumber>JN225965</AccessionNumber>
                        <AccessionNumber>JN225966</AccessionNumber>
                        <AccessionNumber>JN225967</AccessionNumber>
                        <AccessionNumber>JN225968</AccessionNumber>
                        <AccessionNumber>JN225969</AccessionNumber>
                        <AccessionNumber>JN225970</AccessionNumber>
                        <AccessionNumber>JN225971</AccessionNumber>
                        <AccessionNumber>JN225972</AccessionNumber>
                        <AccessionNumber>JN225973</AccessionNumber>
                        <AccessionNumber>JN225974</AccessionNumber>
                        <AccessionNumber>JN225975</AccessionNumber>
                        <AccessionNumber>JN225976</AccessionNumber>
                        <AccessionNumber>JN225977</AccessionNumber>
                        <AccessionNumber>JN225978</AccessionNumber>
                        <AccessionNumber>JN225979</AccessionNumber>
                        <AccessionNumber>JN225980</AccessionNumber>
                        <AccessionNumber>JN225981</AccessionNumber>
                        <AccessionNumber>JN225982</AccessionNumber>
                        <AccessionNumber>JN225983</AccessionNumber>
                        <AccessionNumber>JN225984</AccessionNumber>
                        <AccessionNumber>JN225985</AccessionNumber>
                        <AccessionNumber>JN225986</AccessionNumber>
                        <AccessionNumber>JN225987</AccessionNumber>
                        <AccessionNumber>JN225988</AccessionNumber>
                        <AccessionNumber>JN225989</AccessionNumber>
                        <AccessionNumber>JN225990</AccessionNumber>
                        <AccessionNumber>JN225991</AccessionNumber>
                        <AccessionNumber>JN225992</AccessionNumber>
                        <AccessionNumber>JN225993</AccessionNumber>
                        <AccessionNumber>JN225994</AccessionNumber>
                        <AccessionNumber>JN225995</AccessionNumber>
                        <AccessionNumber>JN225996</AccessionNumber>
                        <AccessionNumber>JN225997</AccessionNumber>
                        <AccessionNumber>JN225998</AccessionNumber>
                        <AccessionNumber>JN225999</AccessionNumber>
                        <AccessionNumber>JN226000</AccessionNumber>
                        <AccessionNumber>JN226001</AccessionNumber>
                        <AccessionNumber>JN226002</AccessionNumber>
                        <AccessionNumber>JN226003</AccessionNumber>
                        <AccessionNumber>JN226004</AccessionNumber>
                        <AccessionNumber>JN226005</AccessionNumber>
                        <AccessionNumber>JN226006</AccessionNumber>
                        <AccessionNumber>JN226007</AccessionNumber>
                        <AccessionNumber>JN226008</AccessionNumber>
                        <AccessionNumber>JN226009</AccessionNumber>
                        <AccessionNumber>JN226010</AccessionNumber>
                        <AccessionNumber>JN226011</AccessionNumber>
                        <AccessionNumber>JN226012</AccessionNumber>
                        <AccessionNumber>JN226013</AccessionNumber>
                        <AccessionNumber>JN226014</AccessionNumber>
                        <AccessionNumber>JN226015</AccessionNumber>
                        <AccessionNumber>JN226016</AccessionNumber>
                        <AccessionNumber>JN226017</AccessionNumber>
                        <AccessionNumber>JN226018</AccessionNumber>
                        <AccessionNumber>JN226019</AccessionNumber>
                        <AccessionNumber>JN226020</AccessionNumber>
                        <AccessionNumber>JN226021</AccessionNumber>
                        <AccessionNumber>JN226022</AccessionNumber>
                        <AccessionNumber>JN226023</AccessionNumber>
                        <AccessionNumber>JN226024</AccessionNumber>
                        <AccessionNumber>JN226025</AccessionNumber>
                        <AccessionNumber>JN226026</AccessionNumber>
                        <AccessionNumber>JN226027</AccessionNumber>
                        <AccessionNumber>JN226028</AccessionNumber>
                        <AccessionNumber>JN226029</AccessionNumber>
                        <AccessionNumber>JN226030</AccessionNumber>
                        <AccessionNumber>JN226031</AccessionNumber>
                        <AccessionNumber>JN226032</AccessionNumber>
                        <AccessionNumber>JN226033</AccessionNumber>
                        <AccessionNumber>JN226034</AccessionNumber>
                        <AccessionNumber>JN226035</AccessionNumber>
                        <AccessionNumber>JN226036</AccessionNumber>
                        <AccessionNumber>JN226037</AccessionNumber>
                        <AccessionNumber>JN226038</AccessionNumber>
                        <AccessionNumber>JN226039</AccessionNumber>
                        <AccessionNumber>JN226040</AccessionNumber>
                        <AccessionNumber>JN226041</AccessionNumber>
                        <AccessionNumber>JN226042</AccessionNumber>
                        <AccessionNumber>JN226043</AccessionNumber>
                        <AccessionNumber>JN226044</AccessionNumber>
                        <AccessionNumber>JN226045</AccessionNumber>
                        <AccessionNumber>JN226046</AccessionNumber>
                        <AccessionNumber>JN226047</AccessionNumber>
                        <AccessionNumber>JN226048</AccessionNumber>
                        <AccessionNumber>JN226049</AccessionNumber>
                        <AccessionNumber>JN226050</AccessionNumber>
                        <AccessionNumber>JN226051</AccessionNumber>
                        <AccessionNumber>JN226052</AccessionNumber>
                        <AccessionNumber>JN226053</AccessionNumber>
                        <AccessionNumber>JN226054</AccessionNumber>
                        <AccessionNumber>JN226055</AccessionNumber>
                        <AccessionNumber>JN226056</AccessionNumber>
                        <AccessionNumber>JN226057</AccessionNumber>
                        <AccessionNumber>JN226058</AccessionNumber>
                        <AccessionNumber>JN226059</AccessionNumber>
                        <AccessionNumber>JN226060</AccessionNumber>
                        <AccessionNumber>JN226061</AccessionNumber>
                        <AccessionNumber>JN226062</AccessionNumber>
                        <AccessionNumber>JN226063</AccessionNumber>
                        <AccessionNumber>JN226064</AccessionNumber>
                        <AccessionNumber>JN226065</AccessionNumber>
                        <AccessionNumber>JN226066</AccessionNumber>
                        <AccessionNumber>JN226067</AccessionNumber>
                        <AccessionNumber>JN226068</AccessionNumber>
                        <AccessionNumber>JN226069</AccessionNumber>
                        <AccessionNumber>JN226070</AccessionNumber>
                        <AccessionNumber>JN226071</AccessionNumber>
                        <AccessionNumber>JN226072</AccessionNumber>
                        <AccessionNumber>JN226073</AccessionNumber>
                        <AccessionNumber>JN226074</AccessionNumber>
                        <AccessionNumber>JN226075</AccessionNumber>
                        <AccessionNumber>JN226076</AccessionNumber>
                        <AccessionNumber>JN226077</AccessionNumber>
                        <AccessionNumber>JN226078</AccessionNumber>
                        <AccessionNumber>JN226079</AccessionNumber>
                        <AccessionNumber>JN226080</AccessionNumber>
                        <AccessionNumber>JN226081</AccessionNumber>
                        <AccessionNumber>JN226082</AccessionNumber>
                        <AccessionNumber>JN226083</AccessionNumber>
                        <AccessionNumber>JN226084</AccessionNumber>
                        <AccessionNumber>JN226085</AccessionNumber>
                        <AccessionNumber>JN226086</AccessionNumber>
                        <AccessionNumber>JN226087</AccessionNumber>
                        <AccessionNumber>JN226088</AccessionNumber>
                        <AccessionNumber>JN226089</AccessionNumber>
                        <AccessionNumber>JN226090</AccessionNumber>
                        <AccessionNumber>JN226091</AccessionNumber>
                        <AccessionNumber>JN226092</AccessionNumber>
                        <AccessionNumber>JN226093</AccessionNumber>
                        <AccessionNumber>JN226094</AccessionNumber>
                        <AccessionNumber>JN226095</AccessionNumber>
                        <AccessionNumber>JN226096</AccessionNumber>
                        <AccessionNumber>JN226097</AccessionNumber>
                        <AccessionNumber>JN226098</AccessionNumber>
                        <AccessionNumber>JN226099</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2011</Year>
                <Month>09</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Antiviral Res</MedlineTA>
            <NlmUniqueID>8109699</NlmUniqueID>
            <ISSNLinking>0166-3542</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005061" MajorTopicYN="N" Type="Geographic">Europe, Eastern</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019083" MajorTopicYN="N" Type="Geographic">Mediterranean Region</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008877" MajorTopicYN="N" Type="Geographic">Middle East</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2011</Year>
                <Month>03</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2011</Year>
                <Month>07</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2011</Year>
                <Month>08</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>9</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>9</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2012</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21920388</ArticleId>
            <ArticleId IdType="pii">S0166-3542(11)00414-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.antiviral.2011.08.013</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">21915864</PMID>
        <DateCompleted>
            <Year>2012</Year>
            <Month>01</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2013</Year>
            <Month>11</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1096-9071</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>83</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medical virology</Title>
                <ISOAbbreviation>J. Med. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1905-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.22192</ELocationID>
            <Abstract>
                <AbstractText>Evaluation of resistance pattern in patients with chronic hepatitis B. Retrospective study of hepatitis B virus (HBV) resistance mutations in patients found viraemic after first-line treatment. HBV viral load was determined by a real-time polymerase chain reaction and the substitutions in HBV-DNA were studied by polymerase sequencing test. First line treatment had failed in 12 out of 33 patients (36%) receiving anti-HBV drugs. The 12 patients with persistent viraemia were all lamivudine (LAM) experienced and 7 had a polymerase sequencing test available. LAM substitution mutations L180M + M204V/I were found in six out of seven cases, with an accompanying V173L mutation in three cases. These mutations were also related with changes in HBsAg. The use of potent drugs in the first line anti-HBV therapy may reduce the resistance mutations in the future.</AbstractText>
                <CopyrightInformation>Copyright ¬© 2011 Wiley-Liss, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Taramasso</LastName>
                    <ForeName>Lucia</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases Department, San Martino Hospital and University of Genoa, Genoa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caligiuri</LastName>
                    <ForeName>Patrizia</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Biagio</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bruzzone</LastName>
                    <ForeName>Bianca</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosso</LastName>
                    <ForeName>Raffaella</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Icardi</LastName>
                    <ForeName>Giancarlo</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Viscoli</LastName>
                    <ForeName>Claudio</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Med Virol</MedlineTA>
            <NlmUniqueID>7705876</NlmUniqueID>
            <ISSNLinking>0146-6615</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2T8Q726O95</RegistryNumber>
                <NameOfSubstance UI="D019259">Lamivudine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019259" MajorTopicYN="N">Lamivudine</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>9</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>9</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2012</Year>
                <Month>1</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21915864</ArticleId>
            <ArticleId IdType="doi">10.1002/jmv.22192</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20674805</PMID>
        <DateCompleted>
            <Year>2010</Year>
            <Month>11</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2010</Year>
            <Month>08</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-9824</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>24</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Infectious disease clinics of North America</Title>
                <ISOAbbreviation>Infect. Dis. Clin. North Am.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antiviral drug resistance: mechanisms and clinical implications.</ArticleTitle>
            <Pagination>
                <MedlinePgn>809-33</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.idc.2010.07.001</ELocationID>
            <Abstract>
                <AbstractText>Antiviral drug resistance is an increasing concern in immunocompromised patient populations, where ongoing viral replication and prolonged drug exposure lead to the selection of resistant strains. Rapid diagnosis of resistance can be made by associating characteristic viral mutations with resistance to various drugs as determined by phenotypic assays. Management of drug resistance includes optimization of host factors and drug delivery, selection of alternative therapies based on knowledge of mechanisms of resistance, and the development of new antivirals. This article discusses drug resistance in herpesviruses and hepatitis B.</AbstractText>
                <CopyrightInformation>Copyright 2010 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Strasfeld</LastName>
                    <ForeName>Lynne</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Oregon Health &amp; Science University, Portland, OR 97239, USA. strasfel@ohsu.edu</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chou</LastName>
                    <ForeName>Sunwen</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>AI39938</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016439">Corrected and Republished Article</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Infect Dis Clin North Am</MedlineTA>
            <NlmUniqueID>8804508</NlmUniqueID>
            <ISSNLinking>0891-5520</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="ErratumIn">
                <RefSource>Infect Dis Clin North Am. 2010 Sep;24(3):xi</RefSource>
            </CommentsCorrections>
            <CommentsCorrections RefType="RepublishedFrom">
                <RefSource>Infect Dis Clin North Am. 2010 Jun;24(2):413-37</RefSource>
                <PMID Version="1">20466277</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003586" MajorTopicYN="N">Cytomegalovirus Infections</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006561" MajorTopicYN="N">Herpes Simplex</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006562" MajorTopicYN="N">Herpes Zoster</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>8</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>8</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2010</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20674805</ArticleId>
            <ArticleId IdType="pii">S0891-5520(10)00056-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.idc.2010.07.001</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20586936</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>01</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2013</Year>
            <Month>11</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1365-2893</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17 Suppl 1</Volume>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of viral hepatitis</Title>
                <ISOAbbreviation>J. Viral Hepat.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B.</ArticleTitle>
            <Pagination>
                <MedlinePgn>66-72</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Antiviral therapy is a potentially successful approach for the treatment of patients with Hepatitis B virus (HBV) infection. One antiviral agent is the nucleoside analogue adefovir dipivoxil (ADV). Its efficiency is compromised by the emergence of drug-resistant HBV mutants. Although three major ADV-resistant mutations of HBV are known, rtA181T/V and rtN236T, HBV mutations associated with ADV resistance have not been fully identified. We analyzed DNA sequences that covered a 244 base pair region of the HBV polymerase gene from patients with clinical manifestations of ADV resistance. A novel pattern of amino acid substitutions in HBV polymerase was detected in 26 out of 86 patients. This mutant exhibited a substitution of glycine for glutamic acid at residue 218 (rtE218G). Transient transfection of the HBV replication-competent construct including the rtE218G mutation was performed in HepG2 cells in order to determine the relevance of this mutation to ADV resistance. Phenotypic analyses demonstrated that the rtE218G mutation could independently confer resistance to ADV in vitro, with a 50% inhibitory concentration (IC(50)) 5.5-fold higher than wild-type HBV. RtE218G-mutated HBV also showed a decreased replication capacity in vitro, equal to 87% of wild-type HBV. The present study showed that the rtE218G mutation may be a novel ADV-resistant mutation. Further work will focus on resistance surveillance and cross-resistance analyses, and the molecular mechanisms involved.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>L J</ForeName>
                    <Initials>LJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>J H</ForeName>
                    <Initials>JH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Du</LastName>
                    <ForeName>S C</ForeName>
                    <Initials>SC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>J H</ForeName>
                    <Initials>JH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>R F</ForeName>
                    <Initials>RF</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Viral Hepat</MedlineTA>
            <NlmUniqueID>9435672</NlmUniqueID>
            <ISSNLinking>1352-0504</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D063065">Organophosphonates</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>JAC85A2161</RegistryNumber>
                <NameOfSubstance UI="D000225">Adenine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>U6Q8Z01514</RegistryNumber>
                <NameOfSubstance UI="C106812">adefovir dipivoxil</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063065" MajorTopicYN="N">Organophosphonates</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>7</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>3</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20586936</ArticleId>
            <ArticleId IdType="pii">JVH1273</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1365-2893.2010.01273.x</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20034521</PMID>
        <DateCompleted>
            <Year>2010</Year>
            <Month>05</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2010</Year>
            <Month>03</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-9096</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>85</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Antiviral research</Title>
                <ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-na√Øve Chinese patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>512-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2009.12.006</ELocationID>
            <Abstract>
                <AbstractText>Full-length hepatitis B virus (HBV) reverse transcriptase (RT) sequences were amplified and sequenced among 192 nucleos(t)ide analogue (NA)-na√Øve Chinese patients with chronic hepatitis B. Deduced amino acids (AAs) at 42 previously reported potential NA resistance (NAr) mutation positions in RT region were analyzed. Patients were found with either B-genotype (28.65%) or C-genotype (71.35%) infections. Rt53, rt91, rt124, rt134, rt221, rt224, rt238 and rt256 were identified as B- and C-genotype-dependent polymorphic AA positions. AA substitutions at 11 classical NAr mutation positions, i.e. rt80, rt169, rt173, rt180, rt181, rt184, rt194, rt202, rt204, rt236 and rt250, were not detected. However, potential NAr mutations were found in 30.73% (59/192) isolates, which involved 18 positions including rt53, rt207, rt229, rt238 and rt256, etc. The concomitant AA changes of HBsAg occurred in 16.67% (32/192) isolates including sG145R mutation. One-third of mutation positions were located in functional RT domains (e.g. rt207 and rt233), A-B interdomains (overlapping HBsAg 'a' determinant and showing most concomitant immune-associated mutations) and non-A-B interdomains (e.g. rt191 and rt213), respectively. Genotypes B and C each showed several preferred positions to mutate. These results might provide insights into understanding the evolution and selection basis of NAr HBV strains under antiviral therapy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Bao-Ming</ForeName>
                    <Initials>BM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Peking University Health Science Center, Xueyuan Road 38, Haidian District, 100191 Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Tong</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xiao-Guang</ForeName>
                    <Initials>XG</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Jian-Ping</ForeName>
                    <Initials>JP</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Ping</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Jing-Xian</ForeName>
                    <Initials>JX</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Zhi-Yong</ForeName>
                    <Initials>ZY</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Wen-Peng</ForeName>
                    <Initials>WP</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Xie-Wen</ForeName>
                    <Initials>XW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yu-Hua</ForeName>
                    <Initials>YH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiao</LastName>
                    <ForeName>Xiu-Juan</ForeName>
                    <Initials>XJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hou</LastName>
                    <ForeName>Chun-Sheng</ForeName>
                    <Initials>CS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhuang</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2009</Year>
                <Month>12</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Antiviral Res</MedlineTA>
            <NlmUniqueID>8109699</NlmUniqueID>
            <ISSNLinking>0166-3542</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2009</Year>
                <Month>07</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2009</Year>
                <Month>10</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2009</Year>
                <Month>12</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>12</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>12</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2010</Year>
                <Month>5</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20034521</ArticleId>
            <ArticleId IdType="pii">S0166-3542(09)00545-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.antiviral.2009.12.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19737565</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>12</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2009</Year>
            <Month>10</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1528-0012</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>137</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2009</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Gastroenterology</Title>
                <ISOAbbreviation>Gastroenterology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hepatitis B virus resistance to nucleos(t)ide analogues.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1593-608.e1-2</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1053/j.gastro.2009.08.063</ELocationID>
            <Abstract>
                <AbstractText>Patients with chronic hepatitis B (CHB) can be successfully treated using nucleos(t)ide analogs (NA), but drug-resistant hepatitis B virus (HBV) mutants frequently arise, leading to treatment failure and progression to liver disease. There has been much research into the mechanisms of resistance to NA and selection of these mutants. Five NA have been approved by the US Food and Drug Administration for treatment of CHB; it is unlikely that any more NA will be developed in the near future, so it is important to better understand mechanisms of cross-resistance (when a mutation that mediates resistance to one NA also confers resistance to another) and design more effective therapeutic strategies for these 5 agents. The genes that encode the polymerase and envelope proteins of HBV overlap, so resistance mutations in polymerase usually affect the hepatitis B surface antigen; these alterations affect infectivity, vaccine efficacy, pathogenesis of liver disease, and transmission throughout the population. Associations between HBV genotype and resistance phenotype have allowed cross-resistance profiles to be determined for many commonly detected mutants, so genotyping assays can be used to adapt therapy. Patients that experience virologic breakthrough or partial response to their primary therapy can often be successfully treated with a second NA, if this drug is given at early stages of these events. However, best strategies for preventing NA resistance include first-line use of the most potent antivirals with a high barrier to resistance. It is important to continue basic research into HBV replication and pathogenic mechanisms to identify new therapeutic targets, develop novel antiviral agents, design combination therapies that prevent drug resistance, and decrease the incidence of complications of CHB.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zoulim</LastName>
                    <ForeName>Fabien</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>INSERM, U871, Lyon, France. fabien.zoulim@inserm.fr</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Locarnini</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 AI071820</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AIO60449</GrantID>
                    <Agency>PHS HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2009</Year>
                <Month>09</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Gastroenterology</MedlineTA>
            <NlmUniqueID>0374630</NlmUniqueID>
            <ISSNLinking>0016-5085</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009705">Nucleosides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009711">Nucleotides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018894">Reverse Transcriptase Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009705" MajorTopicYN="N">Nucleosides</DescriptorName>
                <QualifierName UI="Q000819" MajorTopicYN="Y">agonists</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009711" MajorTopicYN="N">Nucleotides</DescriptorName>
                <QualifierName UI="Q000819" MajorTopicYN="Y">agonists</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018894" MajorTopicYN="N">Reverse Transcriptase Inhibitors</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <NumberOfReferences>125</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2009</Year>
                <Month>06</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2009</Year>
                <Month>08</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2009</Year>
                <Month>08</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>9</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>9</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>12</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19737565</ArticleId>
            <ArticleId IdType="pii">S0016-5085(09)01556-X</ArticleId>
            <ArticleId IdType="doi">10.1053/j.gastro.2009.08.063</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19399794</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>06</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>49</Volume>
                    <Issue>5 Suppl</Issue>
                    <PubDate>
                        <Year>2009</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antiviral resistance and hepatitis B therapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>S174-84</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.22900</ELocationID>
            <Abstract>
                <AbstractText>The management of chronic hepatitis B currently rests with long-term therapy using oral nucleoside analogs. The major limitation of long-term therapy is antiviral resistance. Antiviral resistance is due to the high rate of mutations that can occur during hepatitis B virus (HBV) replication and the selection of these mutants due to a replication advantage in the presence of the antiviral agent. Indeed, high rates of antiviral resistance have been found with long-term use of lamivudine, in up to 76% of patients treated for 5 years or more. Rates of antiviral resistance are lower with adefovir therapy, approximately 30% at 5 years. Newer more potent nucleoside analogs (tenofovir and entecavir) have proven to have much lower rates of antiviral resistance (&lt;1% after 2 years in treatment-na√Øve subjects), but the long-term rates of resistance have yet to be fully defined. The appearance of these viral mutations (genotypic resistance) is usually followed by rises in HBV DNA levels (virological breakthrough) and then by rises in serum aminotransferase levels (biochemical breakthrough). The appearance of antiviral resistance can be accompanied by a transient but occasionally severe exacerbation of the underlying liver disease which in some instances has led to acute liver failure. Combinations of nucleoside analogs may offer an approach to preventing antiviral resistance, but the efficacy and safety of this approach have yet to be shown. A future research priority is to identify new agents active against HBV that target different steps in the viral life-cycle and might provide effective means to circumvent the antiviral resistance of nucleoside analogs.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ghany</LastName>
                    <ForeName>Marc G</ForeName>
                    <Initials>MG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Liver Diseases Branch, Division of Digestive Diseases and Nutrition, National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892-1800, USA. Marcg@intra.niddk.nih.gov</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doo</LastName>
                    <ForeName>Edward C</ForeName>
                    <Initials>EC</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>Z01 DK054517-01</GrantID>
                    <Acronym>NULL</Acronym>
                    <Agency>Intramural NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016447">Consensus Development Conference, NIH</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <NumberOfReferences>84</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>4</Month>
                <Day>29</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>4</Month>
                <Day>29</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>6</Month>
                <Day>6</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19399794</ArticleId>
            <ArticleId IdType="doi">10.1002/hep.22900</ArticleId>
            <ArticleId IdType="pmc">PMC2707848</ArticleId>
            <ArticleId IdType="mid">NIHMS96699</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Antivir Ther. 2005;10(5):625-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16152756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2005 Oct;129(4):1198-209</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16230074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2005 Nov;4(11):928-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16264436</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2005 Dec;42(6):1414-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16317671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Mar 9;354(10):1001-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16525137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Mar 9;354(10):1011-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16525138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2006 Mar 15;23(6):787-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16556181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Apr 27;354(17):1807-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16641397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2006 Jun;130(7):2039-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16762627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Aug;44(2):318-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16871563</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Sep;44(3):703-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16941700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2006 Nov;50(11):3867-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16982790</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Dec;46(6):1695-703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18027877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2007 Dec 20;357(25):2576-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18094378</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2007;12(8):1295-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18240869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2008 Feb;134(2):405-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18242209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Nov;44(5):1117-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17058221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2006 Dec 1;194(11):1471-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17083029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Dec;44(6):1656-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17133475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2006 Dec;131(6):1743-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17087951</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2007 Apr;132(4):1574-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17408658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2007;12(3):355-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17591025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Jul;46(1):254-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17596850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2007 Nov 15;196(10):1483-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18008227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2007 Mar;46(3):531-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17239478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Feb;45(2):307-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17256746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Feb;45(2):507-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17256718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2007 Apr;81(8):3992-4001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17267485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2008 May;48(5):728-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18329126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2008 May;48(5):747-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18331765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2008 May;47(5):1473-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18435459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2008 Jun;134(1-2):235-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18339439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2000 Oct;32(4 Pt 1):866-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11003636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2000 Sep;33(3):469-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11020004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2000 Nov;32(5):1078-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11050059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2001 Jan;45(1):138-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11120956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2001 Feb;107(4):449-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11181644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2008;13(3):381-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18572751</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2008 Jul;48(1):99-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18537189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Gastroenterol Hepatol. 2008 Aug;20(8):773-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18617782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2008 Sep;48(3):750-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18752330</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2008 Nov;82(21):10747-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18715933</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2000 Jun;74(11):5257-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10799602</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2000 Jun;31(6):1318-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10827158</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2008 Dec 4;359(23):2442-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19052126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2008 Dec;6(12):1315-41; quiz 1286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18845489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2009 Feb;50(2):227-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19054588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2009 Feb;81(2):147-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19028525</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2009 Feb;136(2):486-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19027013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2001 May;75(10):4771-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11312349</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2001 Oct;34(4 Pt 1):785-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11584376</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Jan;124(1):105-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12512035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Feb 27;348(9):800-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12606734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Feb 27;348(9):808-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12606735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2003 Mar 15;36(6):687-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12627352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Aug;125(2):292-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12891527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2003 Nov;77(21):11833-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14557667</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2003 Dec;39(6):1085-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14642631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2004 Jan;126(1):91-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14699491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Dec;125(6):1714-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14724824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2004 May;40(5):837-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15094233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2004 Sep;48(9):3498-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15328117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Sep 16;351(12):1206-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15371578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2004 Oct;40(4):883-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15382125</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Oct 7;351(15):1521-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15470215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1997 Jul;41(7):1444-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9210663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1998 Jun;27(6):1670-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9620341</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1998 Jul 9;339(2):61-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9654535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1999 Mar;29(3):889-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10051494</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1999 May;73(5):3616-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10196253</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1999 Aug;43(8):1947-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10428918</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1999 Oct 21;341(17):1256-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10528035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2004 Oct;9(5):679-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15535405</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2004 Dec;40(6):1421-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15565615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liver Int. 2005 Jun;25(3):472-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15910483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2005 Jun;41(6):1391-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15915463</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">21686872</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>11</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1757-790X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2009</Volume>
                    <PubDate>
                        <Year>2009</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ case reports</Title>
                <ISOAbbreviation>BMJ Case Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr.06.2008.0287</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">bcr06.2008.0287</ELocationID>
            <Abstract>
                <AbstractText>The benefit of lamivudine (LAM) in hepatitis B virus (HBV) infection is compromised by the progressively increasing emergence of drug-resistant mutant strains. Although the addition of adefovir dipivoxil (ADV) usually induces complete suppression of viral replication, primary non-response to ADV in LAM resistant patients has been reported in a variable percentage of cases. Here we report a case of a patient with HBV infection and hepatocellular carcinoma who started LAM therapy and subsequently developed virological breakthrough. The patient was given ADV, but HBV-DNA negativisation was not reached. However, HBV clearance was obtained when the patient was switched from ADV to tenofovir. Virological evaluations showed two well-known LAM-related mutations (rtL180M and rtM204I) in addition to reverse-transcriptase rtQ215H. This is the first case suggesting that this mutation may have an impact on viral replication. Finally, we also report that rtQ215H is responsive to tenofovir.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Micco</LastName>
                    <ForeName>Lorenzo</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Bologna, Clinical Medicine, via Massarenti 9, Bologna 40138, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fiorino</LastName>
                    <ForeName>Sirio</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Loggi</LastName>
                    <ForeName>Elisabetta</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lorenzini</LastName>
                    <ForeName>Stefania</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vitale</LastName>
                    <ForeName>Giovanni</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cursaro</LastName>
                    <ForeName>Carmela</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Riili</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bernardi</LastName>
                    <ForeName>Mauro</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andreone</LastName>
                    <ForeName>Pietro</ForeName>
                    <Initials>P</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2009</Year>
                <Month>02</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ Case Rep</MedlineTA>
            <NlmUniqueID>101526291</NlmUniqueID>
            <ISSNLinking>1757-790X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>6</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>1</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>1</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21686872</ArticleId>
            <ArticleId IdType="doi">10.1136/bcr.06.2008.0287</ArticleId>
            <ArticleId IdType="pii">bcr06.2008.0287</ArticleId>
            <ArticleId IdType="pmc">PMC3030117</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Intervirology. 2006;49(3):152-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16428891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2003 Dec;38(6):1419-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14647053</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2007 Apr;132(4):1574-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17408658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Feb;45(2):507-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17256718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2004 Nov 19;18(17):2325-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15577546</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2007 Jul;46(1):254-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17596850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2004 Jan;126(1):91-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14699491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2004 Jan;126(1):81-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14699490</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2003 Feb;23(1):89-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12616454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2006 Oct;55(10):1488-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16461777</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2004 Dec;40(6):1421-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15565615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Treat News. 2001 Oct 26;(373):2-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11768879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Comp Hepatol. 2006;5:1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16405720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Sep;44(3):703-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16941700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Heredity (Edinb). 2006 Dec;97(6):389-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16896341</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Feb;44(2):283-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16338024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transplant Proc. 2003 Sep;35(6):2086-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14529849</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2006 May;26(2):162-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16673294</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">18435459</PMID>
        <DateCompleted>
            <Year>2008</Year>
            <Month>08</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>11</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>47</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2008</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1473-82</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.22211</ELocationID>
            <Abstract>
                <AbstractText Label="UNLABELLED">Virologic resistance emerging during entecavir (ETV) therapy for hepatitis B virus (HBV) requires three substitutions in the viral reverse transcriptase (RT), signifying a high barrier to resistance. Two of these substitutions are associated with lamivudine resistance (LVDr) in the tyrosine-methionine-aspartate-aspartate (YMDD) motif (rtM204V and rtL180M), whereas the other occurs at one or more positions specifically associated with ETV resistance (ETVr): rtT184, rtS202, or rtM250. Although a variety of substitutions at these primary ETVr positions arise during ETV therapy, only a subset give rise to clinical virologic breakthrough. To determine the phenotypic impact of observed clinical and potential new ETVr substitutions, a comprehensive panel of clones containing every possible amino acid at the three primary ETVr positions in LVDr HBV was constructed and analyzed in vitro. A range of replication capacities was observed for the panel, but none of the mutations rescued replication of the LVDr mutant to the wild-type level. More clones with residue rtS202 substitutions were severely impaired than those at rtT184 or rtM250. A wide variety of ETV susceptibilities was observed, ranging from approximately eight-fold (no increase over the LVDr parent) to greater than 400-fold over the wild-type. A correlation was identified between clinically observed substitutions and those displaying higher in vitro replication and resistance, especially those from virologic breakthrough patients.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The high number of tolerated and resistant ETVr substitutions is consistent with models predicting that the mechanism for ETVr is through enhancement of LVDr changes in the RT deoxyribonucleotide triphosphate (dNTP)-binding pocket.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Baldick</LastName>
                    <ForeName>Carl J</ForeName>
                    <Initials>CJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Bristol-Myers Squibb Research and Development, Wallingford, CT 06492, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tenney</LastName>
                    <ForeName>Daniel J</ForeName>
                    <Initials>DJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mazzucco</LastName>
                    <ForeName>Charles E</ForeName>
                    <Initials>CE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eggers</LastName>
                    <ForeName>Betsy J</ForeName>
                    <Initials>BJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rose</LastName>
                    <ForeName>Ronald E</ForeName>
                    <Initials>RE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pokornowski</LastName>
                    <ForeName>Kevin A</ForeName>
                    <Initials>KA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Cheng F</ForeName>
                    <Initials>CF</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Colonno</LastName>
                    <ForeName>Richard J</ForeName>
                    <Initials>RJ</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5968Y6H45M</RegistryNumber>
                <NameOfSubstance UI="C413685">entecavir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5Z93L87A1R</RegistryNumber>
                <NameOfSubstance UI="D006147">Guanine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.49</RegistryNumber>
                <NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D019943" MajorTopicYN="Y">Amino Acid Substitution</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2008</Year>
                <Month>4</Month>
                <Day>26</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2008</Year>
                <Month>8</Month>
                <Day>2</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2008</Year>
                <Month>4</Month>
                <Day>26</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">18435459</ArticleId>
            <ArticleId IdType="doi">10.1002/hep.22211</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">17178796</PMID>
        <DateCompleted>
            <Year>2007</Year>
            <Month>05</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0066-4804</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>51</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2007</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Antimicrobial agents and chemotherapy</Title>
                <ISOAbbreviation>Antimicrob. Agents Chemother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.</ArticleTitle>
            <Pagination>
                <MedlinePgn>902-11</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Entecavir (ETV) is a deoxyguanosine analog approved for use for the treatment of chronic infection with wild-type and lamivudine-resistant (LVDr) hepatitis B virus (HBV). In LVD-refractory patients, 1.0 mg ETV suppressed HBV DNA levels to below the level of detection by PCR (&lt;300 copies/ml) in 21% and 34% of patients by Weeks 48 and 96, respectively. Prior studies showed that virologic rebound due to ETV resistance (ETVr) required preexisting LVDr HBV reverse transcriptase substitutions M204V and L180M plus additional changes at T184, S202, or M250. To monitor for resistance, available isolates from 192 ETV-treated patients were sequenced, with phenotyping performed for all isolates with all emerging substitutions, in addition to isolates from all patients experiencing virologic rebounds. The T184, S202, or M250 substitution was found in LVDr HBV at baseline in 6% of patients and emerged in isolates from another 11/187 (6%) and 12/151 (8%) ETV-treated patients by Weeks 48 and 96, respectively. However, use of a more sensitive PCR assay detected many of the emerging changes at baseline, suggesting that they originated during LVD therapy. Only a subset of the changes in ETVr isolates altered their susceptibilities, and virtually all isolates were significantly replication impaired in vitro. Consequently, only 2/187 (1%) patients experienced ETVr rebounds in year 1, with an additional 14/151 (9%) patients experiencing ETVr rebounds in year 2. Isolates from all 16 patients with rebounds were LVDr and harbored the T184 and/or S202 change. Seventeen other novel substitutions emerged during ETV therapy, but none reduced the susceptibility to ETV or resulted in a rebound. In summary, ETV was effective in LVD-refractory patients, with resistant sequences arising from a subset of patients harboring preexisting LVDr/ETVr variants and with approximately half of the patients experiencing a virologic rebound.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tenney</LastName>
                    <ForeName>Daniel J</ForeName>
                    <Initials>DJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA. daniel.tenney@bms.com</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rose</LastName>
                    <ForeName>Ronald E</ForeName>
                    <Initials>RE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baldick</LastName>
                    <ForeName>Carl J</ForeName>
                    <Initials>CJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Levine</LastName>
                    <ForeName>Steven M</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pokornowski</LastName>
                    <ForeName>Kevin A</ForeName>
                    <Initials>KA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walsh</LastName>
                    <ForeName>Ann W</ForeName>
                    <Initials>AW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Cheng-Fang</ForeName>
                    <Initials>CF</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Sharon</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mazzucco</LastName>
                    <ForeName>Charles E</ForeName>
                    <Initials>CE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eggers</LastName>
                    <ForeName>Betsy</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hsu</LastName>
                    <ForeName>Mayla</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plym</LastName>
                    <ForeName>Mary Jane</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Poundstone</LastName>
                    <ForeName>Patricia</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Joanna</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Colonno</LastName>
                    <ForeName>Richard J</ForeName>
                    <Initials>RJ</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2006</Year>
                <Month>12</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Antimicrob Agents Chemother</MedlineTA>
            <NlmUniqueID>0315061</NlmUniqueID>
            <ISSNLinking>0066-4804</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2T8Q726O95</RegistryNumber>
                <NameOfSubstance UI="D019259">Lamivudine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5968Y6H45M</RegistryNumber>
                <NameOfSubstance UI="C413685">entecavir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5Z93L87A1R</RegistryNumber>
                <NameOfSubstance UI="D006147">Guanine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.7.7</RegistryNumber>
                <NameOfSubstance UI="D004259">DNA-Directed DNA Polymerase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004259" MajorTopicYN="N">DNA-Directed DNA Polymerase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019259" MajorTopicYN="N">Lamivudine</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2006</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2007</Year>
                <Month>5</Month>
                <Day>15</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2006</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">17178796</ArticleId>
            <ArticleId IdType="pii">AAC.00833-06</ArticleId>
            <ArticleId IdType="doi">10.1128/AAC.00833-06</ArticleId>
            <ArticleId IdType="pmc">PMC1803124</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2000 Jan 12;283(2):205-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10634336</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1998 Jun;27(6):1711-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9620347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2000 Jun 16;14(9):1111-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10894274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2001 Feb;107(4):449-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11181644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2001 May;75(10):4771-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11312349</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2001 Sep;45(9):2495-501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11502520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2001 Nov 15;184(10):1236-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11679911</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2002 Aug;46(8):2525-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12121928</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Feb 27;348(9):808-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12606735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2003 Feb;23(1):69-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12616452</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2003 Mar 15;36(6):687-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12627352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mutat. 2003 Jul;22(1):79-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12815597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2003 Jul;38(1):96-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12829991</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2003 Jul 25;17(11):1649-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12853747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2003 Dec;39(6):1085-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14642631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2004 Jan;61(1):27-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14670591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2004 Jun;40(6):986-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15158340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2004 Sep;48(9):3498-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15328117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1994 Jun;38(6):1230-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8092819</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1995 May;69(5):3067-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7707534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1997 Jan 4;349(9044):20-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8988118</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1998 Jun;27(6):1670-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9620341</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1998 Dec;42(12):3200-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9835515</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1999 Jan;43(1):190-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9869593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2005 Jun;41(6):1391-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15915463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Liver Dis. 2005;25 Suppl 1:29-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16103979</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2005 Oct;129(4):1198-209</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16230074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2005 Dec;43(6):937-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16168522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2005 Dec;43(6):920-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16246449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2006 Jan;80(2):643-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16378967</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2006 Feb;44(2):283-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16338024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Mar 9;354(10):1001-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16525137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Mar 9;354(10):1011-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16525138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2006 May;50(5):1721-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16641441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Jun;43(6):1385-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16729316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2006 Jun;130(7):2039-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16762627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epidemiol Rev. 2006;28:112-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16754644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2006 Oct;55(10):1488-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16461777</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Dec;44(6):1656-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17133475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2000 Jan 12;283(2):229-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10634339</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
</Publications>